Health care
976 companies, with balance sheet and income statement drawn from SEC filings.
Industries in this sector
Narrow it down
Companies
976 in health care
| Company | Revenue | Net income | Margin | ROE | Revenue 5y | Years |
|---|---|---|---|---|---|---|
| MCKMCKESSON CORP | $403.43 B | $4.76 B | 1.3% | · | +11.1% | 19 |
| CORCencora, Inc. | $321.33 B | $1.55 B | 0.5% | 144.3% | +11.1% | 19 |
| CAHCARDINAL HEALTH INC | $254.25 B | $1.71 B | 0.7% | · | +9.4% | 19 |
| JNJJOHNSON & JOHNSON | $94.19 B | $26.80 B | 28.5% | 35.0% | +2.7% | 19 |
| HCAHCA Healthcare, Inc. | $75.60 B | $6.78 B | 10.3% | · | +8.0% | 16 |
| LLYELI LILLY & Co | $65.18 B | $20.64 B | 31.7% | 101.2% | +21.6% | 19 |
| MRKMerck & Co., Inc. | $65.01 B | $18.25 B | 28.1% | 36.9% | +9.4% | 19 |
| PFEPFIZER INC | $62.58 B | $7.77 B | 12.5% | 8.9% | +8.5% | 19 |
| ABBVAbbVie Inc. | $61.16 B | $4.23 B | 6.9% | · | +6.0% | 15 |
| AZNASTRAZENECA PLC | $58.74 B | $10.22 B | 17.4% | 22.9% | +17.2% | 11 |
| NVSNOVARTIS AG | $54.53 B | $13.98 B | 25.6% | 31.0% | +2.3% | 10 |
| BMYBRISTOL MYERS SQUIBB CO | $48.19 B | $7.05 B | 14.6% | 40.5% | +2.5% | 19 |
| TMOTHERMO FISHER SCIENTIFIC INC. | $44.56 B | $6.70 B | 15.1% | 13.0% | +6.7% | 19 |
| ABTABBOTT LABORATORIES | $44.33 B | $6.52 B | 14.7% | 13.1% | +5.1% | 19 |
| NOCNORTHROP GRUMMAN CORP | $41.95 B | $4.18 B | 10.0% | 26.2% | +2.7% | 19 |
| AMGNAMGEN INC | $36.75 B | $7.71 B | 21.0% | 106.1% | +7.6% | 19 |
| MDTMedtronic plc | $36.36 B | $4.80 B | 13.3% | 9.8% | +3.8% | 14 |
| GILDGILEAD SCIENCES, INC. | $29.44 B | $8.51 B | 28.9% | 40.5% | +3.6% | 19 |
| SYKSTRYKER CORP | $25.12 B | $3.25 B | 12.9% | 15.1% | +11.8% | 19 |
| MMM3M CO | $24.95 B | $3.25 B | 13.1% | 76.1% | -5.0% | 19 |
| DHRDANAHER CORP | $24.57 B | $3.61 B | 14.7% | 7.1% | +2.0% | 19 |
| LHXL3HARRIS TECHNOLOGIES, INC. | $21.86 B | $1.61 B | 7.3% | 8.2% | +3.7% | 17 |
| BDXBECTON DICKINSON & CO | $21.84 B | $1.68 B | 7.7% | 6.5% | +6.3% | 19 |
| TTTrane Technologies plc | $21.32 B | $2.92 B | 13.8% | 36.4% | +11.4% | 19 |
| THCTENET HEALTHCARE CORP | $21.31 B | $2.37 B | 11.1% | · | +3.9% | 18 |
| GEHCGE HealthCare Technologies Inc. | $20.62 B | $2.08 B | 10.4% | 22.1% | · | 5 |
| BSXBOSTON SCIENTIFIC CORP | $20.07 B | $2.89 B | 14.4% | 12.6% | +15.2% | 19 |
| UHSUNIVERSAL HEALTH SERVICES INC | $17.36 B | $1.49 B | 8.7% | 21.4% | +8.5% | 18 |
| TEVATEVA PHARMACEUTICAL INDUSTRIES LTD | $17.26 B | $1.41 B | 8.2% | 21.2% | +0.7% | 17 |
| FMSFresenius Medical Care AG | $14.61 B | $1.11 B | 8.6% | 12.2% | +6.6% | 7 |
| REGNREGENERON PHARMACEUTICALS, INC. | $14.34 B | $4.50 B | 31.4% | 14.9% | +11.0% | 18 |
| VTRSViatris Inc | $14.30 B | -$3.51 B | -24.6% | · | +3.7% | 8 |
| LHLABCORP HOLDINGS INC. | $13.95 B | $876.5 M | 6.3% | 10.5% | -0.0% | 19 |
| DVADAVITA INC. | $13.64 B | $746.8 M | 7.9% | · | +3.4% | 16 |
| KLACKLA CORP | $13.58 B | $4.83 B | 35.6% | 87.5% | +14.4% | 18 |
| BTSGBrightSpring Health Services, Inc. | $12.91 B | $190.7 M | 1.5% | 10.8% | · | 4 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | $12.00 B | $3.95 B | 32.9% | 22.5% | +14.1% | 18 |
| BAXBAXTER INTERNATIONAL INC | $11.24 B | -$957.0 M | -8.5% | -14.6% | -0.7% | 19 |
| DGXQUEST DIAGNOSTICS INC | $11.04 B | $992.0 M | 9.5% | 14.2% | +3.2% | 19 |
| ALCALCON INC | $10.32 B | $980.0 M | 9.5% | 4.5% | +8.8% | 9 |
| BHCBausch Health Companies Inc. | $10.27 B | $157.0 M | 1.2% | · | +5.0% | 18 |
| ISRGINTUITIVE SURGICAL INC | $10.06 B | $2.86 B | 28.6% | 16.7% | +18.2% | 19 |
| BIIBBIOGEN INC. | $9.89 B | $1.29 B | 13.1% | 7.4% | -6.0% | 19 |
| ZTSZoetis Inc. | $9.47 B | $2.67 B | 28.2% | 66.0% | +7.2% | 15 |
| ROKROCKWELL AUTOMATION, INC | $8.34 B | $869.0 M | 9.0% | 24.3% | +5.7% | 19 |
| SOLVSolventum Corp | $8.32 B | $1.56 B | 18.7% | 38.9% | · | 4 |
| ZBHZIMMER BIOMET HOLDINGS, INC. | $8.23 B | $705.1 M | 8.6% | 5.6% | +6.1% | 19 |
| ROPROPER TECHNOLOGIES INC | $7.90 B | $1.54 B | 19.4% | 7.9% | +14.5% | 19 |
| AMEAMETEK INC/ | $7.40 B | $1.48 B | 20.0% | 14.6% | +10.3% | 19 |
| GRMNGARMIN LTD | $7.25 B | $1.66 B | 23.0% | 19.8% | +11.6% | 19 |
| COHRCOHERENT CORP. | $7.12 B | $805.0 M | 11.1% | 9.7% | +18.0% | 18 |
| AAGILENT TECHNOLOGIES, INC. | $6.95 B | $1.30 B | 18.8% | 20.6% | +5.4% | 19 |
| AVTRAvantor, Inc. | $6.55 B | -$530.2 M | -8.1% | -9.2% | +0.5% | 9 |
| OGNOrganon & Co. | $6.22 B | $187.0 M | 3.0% | 30.6% | -1.0% | 7 |
| SNNSMITH & NEPHEW PLC | $6.16 B | $625.0 M | 10.1% | 11.8% | +6.2% | 11 |
| TDYTELEDYNE TECHNOLOGIES INC | $6.12 B | $894.8 M | 14.6% | 8.9% | +14.7% | 18 |
| EWEdwards Lifesciences Corp | $6.07 B | $1.07 B | 17.6% | 10.6% | +6.7% | 18 |
| STESTERIS plc | $5.94 B | $782.3 M | 13.2% | 11.3% | +13.8% | 10 |
| EHCEncompass Health Corp | $5.94 B | $566.2 M | 12.8% | 25.1% | +10.7% | 18 |
| AGLagilon health, inc. | $5.93 B | -$391.3 M | -6.6% | -131.0% | +37.2% | 7 |
| RMDRESMED INC | $5.65 B | $1.52 B | 26.9% | 24.3% | +12.1% | 18 |
| OPCHOption Care Health, Inc. | $5.65 B | $207.6 M | 3.7% | 15.2% | +13.3% | 18 |
| VLTOVeralto Corp | $5.50 B | $940.0 M | 17.1% | 36.6% | · | 5 |
| KEYSKeysight Technologies, Inc. | $5.38 B | $850.0 M | 15.8% | 15.5% | +5.0% | 13 |
| ONCBeOne Medicines Ltd. | $5.34 B | $286.9 M | 5.4% | 7.5% | +76.8% | 12 |
| BLCOBausch & Lomb Corp | $5.10 B | -$360.0 M | -6.9% | -5.6% | +8.4% | 6 |
| ENSGENSIGN GROUP, INC | $5.06 B | $344.0 M | 6.8% | 16.9% | +16.1% | 17 |
| HLFHERBALIFE LTD. | $5.04 B | $228.3 M | 4.5% | · | -1.9% | 18 |
| ELANElanco Animal Health Inc | $4.71 B | -$232.0 M | -4.9% | -3.7% | +7.6% | 10 |
| DXCMDEXCOM INC | $4.66 B | $836.3 M | 17.9% | 34.5% | +19.3% | 17 |
| ILMNILLUMINA, INC. | $4.34 B | $850.0 M | 19.6% | 33.4% | +6.0% | 18 |
| IDXXIDEXX LABORATORIES INC | $4.30 B | $1.06 B | 24.6% | 66.2% | +9.7% | 18 |
| JAZZJazz Pharmaceuticals plc | $4.27 B | -$356.1 M | -8.3% | -8.5% | +12.5% | 17 |
| PRGOPERRIGO Co plc | $4.25 B | -$1.43 B | -33.5% | -39.3% | +0.8% | 14 |
| FTVFortive Corp | $4.16 B | $579.2 M | 13.9% | 7.0% | -2.1% | 12 |
| ARGXARGENX SE | $4.15 B | $1.29 B | 31.1% | 20.2% | +151.5% | 11 |
| COOCOOPER COMPANIES, INC. | $4.09 B | $374.9 M | 9.2% | 4.6% | +11.0% | 18 |
| ALGNALIGN TECHNOLOGY INC | $4.03 B | $410.4 M | 10.2% | 10.4% | +10.3% | 18 |
| MTDMETTLER TOLEDO INTERNATIONAL INC/ | $4.03 B | $869.2 M | 21.6% | · | +5.5% | 15 |
| MKSIMKS INC | $3.93 B | $295.0 M | 7.5% | 11.7% | +11.0% | 18 |
| GMABGENMAB A/S | $3.72 B | $963.0 M | 25.9% | 4.5% | · | 6 |
| ALNYALNYLAM PHARMACEUTICALS, INC. | $3.71 B | $313.7 M | 8.4% | 73.3% | +49.8% | 13 |
| STSensata Technologies Holding plc | $3.70 B | $31.3 M | 0.8% | 1.1% | +4.0% | 17 |
| XRAYDENTSPLY SIRONA Inc. | $3.68 B | -$598.0 M | -16.2% | -36.5% | +2.0% | 19 |
| DRSLeonardo DRS, Inc. | $3.65 B | $278.0 M | 7.6% | 10.5% | +5.6% | 7 |
| TRMBTRIMBLE INC. | $3.59 B | $424.0 M | 11.8% | 7.3% | +2.6% | 18 |
| BRKRBRUKER CORP | $3.44 B | -$8.6 M | -0.2% | -0.4% | +11.6% | 17 |
| ACHCAcadia Healthcare Company, Inc. | $3.31 B | -$1.10 B | -33.0% | -43.9% | +9.7% | 17 |
| SGRYSurgery Partners, Inc. | $3.31 B | -$77.9 M | 3.0% | -4.4% | +12.2% | 12 |
| AHCOAdaptHealth Corp. | $3.24 B | -$70.8 M | -2.0% | -4.6% | +25.2% | 8 |
| BMRNBIOMARIN PHARMACEUTICAL INC | $3.22 B | $348.9 M | 10.8% | 5.9% | +11.6% | 18 |
| BKDBrookdale Senior Living Inc. | $3.19 B | -$262.7 M | -8.2% | · | -2.0% | 18 |
| TERTERADYNE, INC | $3.19 B | $554.0 M | 17.4% | 19.7% | +0.4% | 18 |
| UTHRUNITED THERAPEUTICS Corp | $3.18 B | $1.33 B | 41.9% | 19.7% | +16.5% | 18 |
| WATWATERS CORP | $3.17 B | $642.6 M | 20.3% | 29.3% | +6.0% | 17 |
| VNTVontier Corp | $3.08 B | $406.1 M | 13.2% | 35.4% | +2.6% | 8 |
| WSTWEST PHARMACEUTICAL SERVICES INC | $3.07 B | $493.7 M | 16.1% | 16.9% | +7.4% | 18 |
| AMRXAmneal Pharmaceuticals, Inc. | $3.02 B | $72.1 M | 4.2% | · | +8.7% | 10 |
| GMEDGLOBUS MEDICAL INC | $2.94 B | $537.9 M | 18.3% | 12.3% | +30.1% | 16 |
| NBIXNEUROCRINE BIOSCIENCES INC | $2.86 B | $478.6 M | 16.7% | 16.4% | +22.3% | 17 |
| RVTYREVVITY, INC. | $2.86 B | $241.2 M | 8.4% | 3.2% | +1.4% | 18 |
| QDELQuidelOrtho Corp | $2.73 B | -$1.13 B | -41.5% | -46.1% | +10.4% | 6 |
| NVSTEnvista Holdings Corp | $2.72 B | $47.0 M | 1.7% | 1.6% | +7.1% | 9 |
| PODDINSULET CORP | $2.71 B | $247.1 M | 9.1% | 18.1% | +24.5% | 17 |
| BIOBIO-RAD LABORATORIES, INC. | $2.58 B | $759.9 M | 29.4% | 10.8% | +0.3% | 18 |
| BIO-BBIO-RAD LABORATORIES, INC. | $2.58 B | $759.9 M | 29.4% | 10.8% | +0.3% | 18 |
| CHECHEMED CORP | $2.53 B | $265.2 M | 10.5% | 25.3% | +4.0% | 18 |
| TDOCTeladoc Health, Inc. | $2.53 B | -$200.3 M | -7.9% | -13.9% | +18.3% | 13 |
| RPRXRoyalty Pharma plc | $2.38 B | $770.9 M | 55.7% | 7.7% | +2.3% | 8 |
| ITRIITRON, INC. | $2.37 B | $301.1 M | 12.8% | 19.4% | +1.7% | 18 |
| HIMSHims & Hers Health, Inc. | $2.35 B | $128.4 M | 5.5% | 25.2% | +73.6% | 7 |
| EXELEXELIXIS, INC. | $2.32 B | $782.6 M | 33.7% | 35.5% | +18.6% | 17 |
| NTRANatera, Inc. | $2.31 B | -$208.2 M | -9.0% | -14.3% | +42.6% | 13 |
| ENOVEnovis CORP | $2.25 B | -$1.18 B | -52.7% | -58.5% | +14.9% | 17 |
| ICUIICU MEDICAL INC | $2.23 B | $732,000 | 0.0% | 0.0% | +11.9% | 19 |
| SRPTSarepta Therapeutics, Inc. | $2.20 B | -$713.4 M | -32.5% | -53.5% | +32.4% | 12 |
| PRVAPrivia Health Group, Inc. | $2.12 B | $22.9 M | 1.4% | 3.3% | +21.0% | 7 |
| QGENQIAGEN N.V. | $2.09 B | $424.9 M | 20.3% | 11.6% | +2.2% | 18 |
| RDNTRadNet, Inc. | $2.04 B | -$18.7 M | 0.8% | -1.9% | +13.7% | 17 |
| TFXTELEFLEX INC | $1.99 B | -$905.6 M | -45.4% | -24.5% | -4.7% | 18 |
| EYENational Vision Holdings, Inc. | $1.99 B | $29.6 M | 1.5% | 3.5% | +3.0% | 11 |
| MRNAModerna, Inc. | $1.94 B | -$2.82 B | -145.2% | -28.9% | +19.3% | 10 |
| MDPediatrix Medical Group, Inc. | $1.91 B | $165.4 M | 8.6% | 20.3% | +2.0% | 14 |
| MSAMSA Safety Inc | $1.87 B | $278.9 M | 14.9% | 22.2% | +6.8% | 18 |
| ITGRInteger Holdings Corp | $1.85 B | $102.8 M | 5.5% | 6.1% | +11.5% | 17 |
| HCSGHEALTHCARE SERVICES GROUP INC | $1.84 B | $59.1 M | · | 11.7% | +0.9% | 18 |
| PTCTPTC THERAPEUTICS, INC. | $1.73 B | $682.6 M | 39.4% | · | +35.4% | 15 |
| IARTINTEGRA LIFESCIENCES HOLDINGS CORP | $1.64 B | -$516.5 M | -31.6% | -39.9% | +3.6% | 18 |
| LNTHLantheus Holdings, Inc. | $1.54 B | $233.6 M | 15.2% | 21.4% | +35.3% | 13 |
| PAHCPHIBRO ANIMAL HEALTH CORP | $1.52 B | $99.7 M | 6.6% | 29.7% | +12.7% | 15 |
| NHCNATIONAL HEALTHCARE CORP | $1.52 B | $120.0 M | 8.1% | 11.7% | +8.1% | 17 |
| MMSIMERIT MEDICAL SYSTEMS INC | $1.52 B | $128.5 M | 8.5% | 8.7% | +9.5% | 17 |
| ALKSAlkermes plc. | $1.48 B | $241.7 M | 16.4% | 14.7% | +7.3% | 17 |
| LFSTLifeStance Health Group, Inc. | $1.42 B | $9.7 M | 0.7% | 0.7% | · | 6 |
| ADUSAddus HomeCare Corp | $1.42 B | $95.9 M | 6.7% | 9.3% | +13.2% | 17 |
| PENPenumbra Inc | $1.40 B | $177.7 M | 12.7% | 13.8% | +20.2% | 13 |
| HALOHALOZYME THERAPEUTICS, INC. | $1.40 B | $316.9 M | 22.7% | 153.6% | +39.2% | 17 |
| LIVNLivaNova PLC | $1.39 B | -$242.5 M | -17.5% | -19.2% | +8.2% | 12 |
| CNMDCONMED Corp | $1.37 B | $47.1 M | 3.4% | 4.7% | +9.8% | 17 |
| HAEHAEMONETICS CORP | $1.33 B | $97.3 M | 7.3% | 12.0% | +8.9% | 18 |
| PGNYProgyny, Inc. | $1.29 B | $58.5 M | 4.5% | 12.5% | +30.2% | 9 |
| CURLFCuraleaf Holdings, Inc. | $1.27 B | -$231.1 M | -18.0% | -28.6% | · | 5 |
| INDVIndivior Pharmaceuticals, Inc. | $1.24 B | $210.0 M | 16.9% | · | · | 4 |
| TECHBIO-TECHNE Corp | $1.22 B | $181.9 M | 15.0% | 9.0% | +5.5% | 18 |
| TRLVTrulieve Cannabis Corp. | $1.18 B | -$122.2 M | -10.3% | -10.2% | +17.8% | 7 |
| SHCSotera Health Co | $1.16 B | $77.9 M | 6.7% | 15.4% | +7.3% | 7 |
| NVAXNOVAVAX INC | $1.12 B | $440.3 M | 39.2% | · | +18.8% | 16 |
| PBHPrestige Consumer Healthcare Inc. | $1.09 B | $190.3 M | 17.5% | 10.2% | +2.9% | 17 |
| EMBCEmbecta Corp. | $1.08 B | $95.4 M | 8.8% | · | -0.1% | 6 |
| ACADACADIA PHARMACEUTICALS INC | $1.07 B | $391.0 M | 36.5% | 39.9% | +19.4% | 17 |
| LEGNLegend Biotech Corp | $1.03 B | -$296.8 M | -28.8% | -29.1% | +68.8% | 8 |
| TNDMTANDEM DIABETES CARE INC | $1.01 B | -$204.7 M | -20.2% | -97.9% | +15.3% | 14 |
| ONTOONTO INNOVATION INC. | $1.01 B | $136.8 M | 13.6% | 6.8% | +12.6% | 17 |
| CGNXCOGNEX CORP | $994.4 M | $114.4 M | 11.5% | 7.6% | +4.2% | 18 |
| GHGuardant Health, Inc. | $982.0 M | -$416.3 M | -42.4% | · | +27.9% | 9 |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | $958.4 M | -$288.3 M | -30.1% | -42.5% | · | 10 |
| PNTGPennant Group, Inc. | $947.7 M | $29.6 M | 3.6% | 8.6% | +19.4% | 9 |
| IONSIONIS PHARMACEUTICALS INC | $943.7 M | -$381.4 M | -40.4% | -70.8% | +5.3% | 18 |
| MIRMirion Technologies, Inc. | $925.4 M | $28.8 M | 3.2% | 1.7% | · | 7 |
| BMIBADGER METER INC | $916.7 M | $141.6 M | 15.5% | 21.5% | +16.6% | 17 |
| TLRYTilray Brands, Inc. | $915.5 M | -$121.4 M | -11.5% | -7.8% | +12.3% | 10 |
| INSPInspire Medical Systems, Inc. | $912.0 M | $145.4 M | 15.9% | 19.8% | +51.2% | 9 |
| ANIPANI PHARMACEUTICALS INC | $883.4 M | $78.3 M | 8.9% | 16.6% | +33.5% | 17 |
| NVMINOVA LTD. | $880.6 M | $259.2 M | 29.4% | 23.1% | +26.7% | 17 |
| BCRXBIOCRYST PHARMACEUTICALS INC | $874.8 M | $263.9 M | · | · | +117.9% | 17 |
| WRBYWarby Parker Inc. | $871.9 M | $1.6 M | 0.2% | 0.5% | +17.2% | 7 |
| NEOGNEOGEN CORP | $870.4 M | -$7.9 M | -0.9% | -0.4% | +13.2% | 17 |
| HRMYHarmony Biosciences Holdings, Inc. | $868.5 M | $158.7 M | 18.3% | 20.8% | +40.3% | 7 |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | $829.4 M | -$1.6 M | · | -0.5% | +56.6% | 15 |
| TLXTelix Pharmaceuticals Ltd | $803.8 M | -$7.1 M | -0.9% | -1.9% | · | 4 |
| USPHU S PHYSICAL THERAPY INC | $781.0 M | $39.6 M | 7.4% | 8.2% | +13.0% | 17 |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | $780.6 M | $62.9 M | 8.1% | 23.7% | +20.3% | 10 |
| ATECAlphatec Holdings, Inc. | $764.2 M | -$143.4 M | -18.8% | · | +39.5% | 17 |
| CORTCORCEPT THERAPEUTICS INC | $761.4 M | $99.7 M | 13.1% | 15.0% | +16.6% | 15 |
| IRTCiRhythm Holdings, Inc. | $747.1 M | -$44.6 M | -6.0% | -36.6% | +23.0% | 12 |
| RGENREPLIGEN CORP | $738.3 M | $48.9 M | 6.6% | 2.4% | +15.0% | 16 |
| PCRXPacira BioSciences, Inc. | $726.4 M | $7.0 M | 1.0% | 1.0% | +11.1% | 17 |
| AMPHAmphastar Pharmaceuticals, Inc. | $719.9 M | $98.1 M | 13.6% | 12.9% | +15.5% | 14 |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | $719.0 M | -$38.5 M | -5.4% | -3.7% | +6.7% | 16 |
| AVNSAVANOS MEDICAL, INC. | $701.2 M | -$72.9 M | -10.4% | -9.1% | -0.4% | 14 |
| KNSAKiniksa Pharmaceuticals International, | $677.6 M | $59.0 M | 8.7% | 11.7% | · | 5 |
| RAREUltragenyx Pharmaceutical Inc. | $673.0 M | -$575.0 M | -85.4% | · | +19.9% | 10 |
| NVCRNovoCure Ltd | $655.4 M | -$136.2 M | -20.8% | -38.9% | +5.8% | 13 |
| TXG10x Genomics, Inc. | $642.8 M | -$43.5 M | -6.8% | -5.8% | +16.6% | 9 |
| AXSMAxsome Therapeutics, Inc. | $638.5 M | -$183.2 M | -28.7% | -252.1% | · | 4 |
| TGTXTG THERAPEUTICS, INC. | $616.3 M | $447.2 M | 72.6% | 102.8% | +426.7% | 10 |
| INSMINSMED Inc | $606.4 M | -$1.28 B | -210.5% | -249.3% | +29.8% | 16 |
| TMDXTransMedics Group, Inc. | $605.5 M | $190.3 M | 31.4% | 54.2% | +88.2% | 8 |
| UFPTUFP TECHNOLOGIES INC | $602.8 M | $68.3 M | 11.3% | 17.8% | +27.4% | 17 |
| ALVOAlvotech | $586.3 M | $27.9 M | 4.8% | · | +54.5% | 6 |
| HCMHUTCHMED (China) Ltd | $548.5 M | $456.9 M | 83.4% | 45.7% | +19.2% | 12 |
| ATRCAtriCure, Inc. | $534.5 M | -$11.4 M | -2.1% | -2.4% | +20.9% | 17 |
| MIRMMirum Pharmaceuticals, Inc. | $521.3 M | -$23.4 M | -4.5% | -8.6% | · | 6 |
| VCYTVERACYTE, INC. | $517.1 M | $66.4 M | 12.8% | 5.3% | +34.5% | 15 |
| ADMAADMA BIOLOGICS, INC. | $510.2 M | $146.9 M | 28.8% | 35.6% | +64.6% | 15 |
| GKOSGLAUKOS Corp | $507.4 M | -$187.7 M | -37.0% | -26.4% | +17.7% | 13 |
| BBIOBridgeBio Pharma, Inc. | $502.1 M | -$732.9 M | -146.0% | · | +127.4% | 7 |
| CAMTCAMTEK LTD | $496.1 M | $50.7 M | 10.2% | 8.7% | +26.1% | 17 |
| TVTXTravere Therapeutics, Inc. | $490.7 M | -$25.5 M | -5.2% | -29.4% | +19.9% | 15 |
| ZLABZai Lab Ltd | $460.2 M | -$175.5 M | -38.1% | -22.6% | +56.5% | 8 |
| COHUCOHU INC | $453.0 M | -$74.3 M | -16.4% | -9.0% | -6.6% | 17 |
| TARSTarsus Pharmaceuticals, Inc. | $451.4 M | -$66.4 M | -14.7% | -23.4% | · | 6 |
| AORTARTIVION, INC. | $441.3 M | $9.8 M | 2.2% | 2.7% | +11.8% | 17 |
| WGSGeneDx Holdings Corp. | $427.5 M | -$21.0 M | -4.9% | -7.6% | +19.0% | 7 |
| MDXGMIMEDX GROUP, INC. | $418.6 M | $48.6 M | 11.6% | 21.6% | +11.0% | 16 |
| INVAInnoviva, Inc. | $411.3 M | $271.2 M | 65.9% | 29.1% | +4.1% | 17 |
| IMAXIMAX CORP | $410.2 M | $34.9 M | 11.1% | 10.9% | +24.5% | 17 |
| ARDXARDELYX, INC. | $407.3 M | -$61.6 M | -15.1% | -36.2% | +121.9% | 13 |
| KRYSKrystal Biotech, Inc. | $389.1 M | $204.8 M | 52.6% | 18.9% | · | 5 |
| CDNACareDx, Inc. | $379.8 M | -$21.4 M | -5.6% | -6.3% | +14.6% | 14 |
| TWSTTwist Bioscience Corp | $376.6 M | -$77.7 M | -20.6% | -16.4% | +33.1% | 9 |
| ARQTArcutis Biotherapeutics, Inc. | $376.1 M | -$16.1 M | -4.3% | -9.3% | · | 6 |
| INMDInMode Ltd. | $370.5 M | $93.8 M | 25.3% | 13.5% | +12.4% | 9 |
| MNKDMANNKIND CORP | $349.0 M | $5.9 M | 1.7% | · | +39.9% | 16 |
| TRNSTRANSCAT INC | $331.9 M | $5.4 M | 1.6% | 1.8% | +13.9% | 17 |
| PRCTPROCEPT BioRobotics Corp | $308.1 M | -$95.6 M | -31.0% | -24.9% | +109.0% | 6 |
| XERSXeris Biopharma Holdings, Inc. | $291.8 M | $554,000 | 0.2% | · | +70.2% | 6 |
| AUPHAurinia Pharmaceuticals Inc. | $283.1 M | $287.2 M | 101.5% | 59.9% | +41.4% | 8 |
| ADPTAdaptive Biotechnologies Corp | $277.0 M | -$59.5 M | -21.5% | -28.2% | +23.0% | 9 |
| VCELVericel Corp | $276.3 M | $16.5 M | 6.0% | 5.1% | +17.3% | 17 |
| HROWHARROW, INC. | $272.3 M | -$5.1 M | -1.9% | -8.4% | +41.0% | 13 |
| LGNDLIGAND PHARMACEUTICALS INC | $268.1 M | $124.5 M | 46.4% | 13.5% | +10.4% | 17 |
| SDGRSchrodinger, Inc. | $255.9 M | -$103.3 M | -40.4% | -26.3% | +18.8% | 7 |
| LMATLEMAITRE VASCULAR INC | $249.6 M | $57.7 M | 23.1% | 15.8% | +14.0% | 17 |
| RCUSArcus Biosciences, Inc. | $247.0 M | -$353.0 M | -142.9% | -63.3% | +25.9% | 9 |
| STAASTAAR SURGICAL CO | $239.4 M | -$80.4 M | -33.6% | -21.7% | +7.9% | 17 |
| AKBAAkebia Therapeutics, Inc. | $236.2 M | -$5.3 M | -2.3% | · | -4.3% | 12 |
| AXGNAxogen, Inc. | $225.2 M | -$15.7 M | -7.0% | -13.5% | +14.9% | 16 |
| IDYAIDEAYA Biosciences, Inc. | $218.7 M | -$113.7 M | -52.0% | -10.9% | +62.1% | 7 |
| ESTAESTABLISHMENT LABS HOLDINGS INC. | $211.1 M | -$51.1 M | -24.2% | -133.3% | +20.0% | 9 |
| SIBNSI-BONE, Inc. | $200.9 M | -$18.9 M | -9.4% | -11.0% | +22.3% | 9 |
| RYTMRHYTHM PHARMACEUTICALS, INC. | $189.8 M | -$196.5 M | -103.6% | -244.5% | · | 10 |
| SNDXSyndax Pharmaceuticals Inc | $172.4 M | -$285.4 M | -165.6% | -161.8% | · | 11 |
| BEAMBeam Therapeutics Inc. | $139.7 M | -$80.0 M | -57.2% | -8.1% | +466.3% | 7 |
| NAGENiagen Bioscience, Inc. | $129.4 M | $17.4 M | 13.4% | 28.3% | +16.9% | 16 |
| IBRXImmunityBio, Inc. | $113.3 M | -$351.4 M | -310.2% | · | +184.8% | 13 |
| BLFSBIOLIFE SOLUTIONS INC | $96.2 M | -$4.6 M | -4.8% | -1.3% | +14.9% | 16 |
| CYTKCYTOKINETICS INC | $88.0 M | -$785.0 M | -891.6% | · | +9.5% | 17 |
| NRIXNurix Therapeutics, Inc. | $84.0 M | -$264.5 M | -314.9% | -49.6% | +36.3% | 7 |
| ABCLAbCellera Biologics Inc. | $75.1 M | -$146.4 M | -194.9% | -14.5% | -20.3% | 7 |
| RXRXRECURSION PHARMACEUTICALS, INC. | $74.7 M | -$644.8 M | -863.4% | -59.5% | +79.9% | 7 |
| VRDNViridian Therapeutics, Inc.\DE | $70.8 M | -$342.6 M | · | -49.2% | +132.2% | 13 |
| VIRVir Biotechnology, Inc. | $68.6 M | -$438.0 M | -638.9% | -45.7% | -2.1% | 9 |
| NTLAIntellia Therapeutics, Inc. | $67.7 M | -$412.7 M | -609.9% | -53.5% | +3.1% | 10 |
| AGIOAGIOS PHARMACEUTICALS, INC. | $54.0 M | -$412.8 M | -764.0% | -30.2% | · | 15 |
| OCULOCULAR THERAPEUTIX, INC | $52.0 M | -$265.9 M | -511.9% | -54.9% | +24.4% | 13 |
| PTGXProtagonist Therapeutics, Inc | $46.0 M | -$130.1 M | -282.8% | -20.2% | +10.0% | 9 |
| WVEWave Life Sciences, Inc. | $42.7 M | -$204.4 M | -478.3% | -56.2% | +16.3% | 11 |
| KYMRKymera Therapeutics, Inc. | $39.2 M | -$311.4 M | -794.0% | -25.8% | +2.9% | 7 |
| NAMSNewAmsterdam Pharma Co N.V. | $22.5 M | -$203.8 M | -905.7% | -28.3% | · | 4 |
| MESOMESOBLAST LTD | $17.2 M | -$102.1 M | -593.9% | -19.0% | -11.8% | 10 |
| QUREuniQure N.V. | $16.1 M | -$199.0 M | -1236.0% | · | -15.6% | 12 |
| RLAYRelay Therapeutics, Inc. | $15.4 M | -$276.5 M | · | -41.1% | -28.6% | 6 |
| JANXJanux Therapeutics, Inc. | $10.0 M | -$113.6 M | -1136.2% | -11.5% | · | 6 |
| ROIVRoivant Sciences Ltd. | $8.3 M | -$299.8 M | · | -6.5% | · | 6 |
| CRNXCrinetics Pharmaceuticals, Inc. | $7.7 M | -$465.3 M | · | -40.2% | +155.3% | 10 |
| XENEXenon Pharmaceuticals Inc. | $7.5 M | -$345.9 M | · | -51.8% | · | 13 |
| CGONCG Oncology, Inc. | $4.0 M | -$161.0 M | · | -21.7% | · | 3 |
| CRSPCRISPR Therapeutics AG | $3.5 M | -$581.6 M | · | -30.2% | +37.3% | 11 |
| CLDXCelldex Therapeutics, Inc. | $1.5 M | -$258.8 M | · | -40.6% | -26.9% | 17 |
| DNLIDenali Therapeutics Inc. | $0 | -$512.5 M | · | -45.7% | · | 10 |
| PRAXPraxis Precision Medicines, Inc. | $0 | -$303.3 M | · | -45.8% | · | 4 |
| RVMDRevolution Medicines, Inc. | $0 | -$1.13 B | · | -58.1% | · | 8 |
| SYRESpyre Therapeutics, Inc. | $0 | -$155.2 M | · | -25.2% | · | 10 |
| VKTXViking Therapeutics, Inc. | $0 | -$359.6 M | · | -47.3% | · | 12 |
| TAKTAKEDA PHARMACEUTICAL CO LTD | JPY 4.58 T | JPY 107.93 B | 2.4% | 1.5% | +6.8% | 9 |
| CAJPYCANON INC | JPY 4.03 T | JPY 243.96 B | 6.5% | 8.1% | -0.2% | 16 |
| RDYDR REDDYS LABORATORIES LTD | INR 325.54 B | INR 56.54 B | 17.6% | 18.4% | +13.3% | 10 |
| NVONOVO NORDISK A S | DKK 309.06 B | DKK 102.43 B | 33.1% | 60.7% | +19.5% | 7 |
| SNYSanofi | EUR 43.63 B | EUR 7.81 B | 18.0% | 10.5% | +3.9% | 11 |
| GSKGSK plc | GBP 32.67 B | GBP 5.72 B | 19.3% | 38.0% | +6.0% | 11 |
| PHGKONINKLIJKE PHILIPS NV | EUR 17.83 B | EUR 895.0 M | 5.0% | 7.8% | +0.6% | 11 |
| GRFSGrifols SA | EUR 7.21 B | EUR 156.9 M | 3.0% | 2.8% | +7.2% | 10 |
| BNTXBioNTech SE | EUR 2.87 B | -EUR 1.14 B | -39.6% | -5.9% | +42.9% | 9 |
| STVNStevanato Group S.p.A. | EUR 1.19 B | EUR 139.8 M | 11.8% | 9.7% | +12.4% | 7 |
| LKFTLakefront Biotherapeutics NV | EUR 1.11 B | EUR 320.9 M | 28.8% | 10.5% | +18.4% | 11 |
| SNDLSNDL Inc. | CAD 946.4 M | -CAD 15.8 M | -1.7% | -1.4% | +73.1% | 7 |
| EVOEvotec SE | EUR 797.0 M | -EUR 196.1 M | -24.6% | -18.9% | +12.3% | 6 |
| ASNDAscendis Pharma A/S | EUR 720.1 M | -EUR 228.0 M | -31.7% | · | +153.0% | 11 |
| IMCRImmunocore Holdings plc | GBP 143.7 M | -GBP 41.2 M | -28.7% | -18.3% | · | 5 |
| COGTCogent Biosciences, Inc. | · | -$328.9 M | · | -73.7% | · | 4 |
| GERNGERON CORP | · | -$83.5 M | · | -33.0% | · | 15 |
| MLTXMoonLake Immunotherapeutics | · | -$227.3 M | · | -60.5% | · | 0 |
| PHVSPharvaris N.V. | · | -EUR 175.7 M | · | -65.2% | · | 0 |
| RGCRegencell Bioscience Holdings Ltd | · | -$11.7 M | · | -128.5% | · | 0 |
| SMMTSummit Therapeutics Inc. | · | -$1.08 B | · | -206.1% | · | 6 |
| CYHCOMMUNITY HEALTH SYSTEMS INC | $12.48 B | $509.0 M | 5.4% | · | +1.2% | 18 |
| ARDTArdent Health, Inc. | $6.32 B | $135.8 M | 3.6% | 11.2% | · | 4 |
| PACSPACS Group, Inc. | $5.29 B | $191.5 M | 3.6% | 23.1% | · | 4 |
| FTREFortrea Holdings Inc. | $2.72 B | -$986.2 M | -36.2% | -102.4% | · | 5 |
| AVAHAveanna Healthcare Holdings, Inc. | $2.43 B | $225.0 M | 9.2% | · | +10.2% | 7 |
| NUSNU SKIN ENTERPRISES, INC. | $1.49 B | $160.2 M | 10.8% | 22.0% | -10.5% | 17 |
| KODKEASTMAN KODAK CO | $1.07 B | -$128.0 M | -12.0% | -20.4% | +0.8% | 17 |
| FOSLFossil Group, Inc. | $1.00 B | -$77.8 M | -7.7% | -61.9% | -9.0% | 18 |
| INNVInnovAge Holding Corp. | $989.7 M | -$2.5 M | -0.1% | -1.1% | +9.2% | 7 |
| USNAUSANA HEALTH SCIENCES INC | $925.3 M | $10.8 M | 1.2% | 2.0% | -4.0% | 17 |
| MYGNMYRIAD GENETICS INC | $824.5 M | -$365.9 M | -44.4% | -68.5% | +8.2% | 18 |
| OFIXOrthofix Medical Inc. | $822.3 M | -$92.2 M | -11.2% | -19.3% | +15.1% | 17 |
| EBSEmergent BioSolutions Inc. | $742.9 M | $52.6 M | 7.1% | 10.5% | -14.0% | 17 |
| MOVMOVADO GROUP INC | $671.3 M | $26.6 M | 4.0% | 5.4% | +5.8% | 17 |
| MOVAAMOVADO GROUP INC | $671.3 M | $26.6 M | 4.0% | 5.4% | +5.8% | 17 |
| GPROGoPro, Inc. | $651.5 M | -$92.6 M | -14.2% | -80.9% | -6.1% | 14 |
| OPKOPKO HEALTH, INC. | $606.9 M | -$225.7 M | -37.2% | -17.1% | -15.8% | 17 |
| BVSBioventus Inc. | $568.1 M | $22.7 M | 4.8% | 13.7% | +12.1% | 7 |
| ORGOOrganogenesis Holdings Inc. | $564.2 M | $37.0 M | 6.6% | 13.2% | +10.8% | 10 |
| ALNTALLIENT INC | $554.5 M | $22.0 M | 4.0% | 7.8% | +8.6% | 16 |
| STLNStarling Oncology, Inc. | $502.7 M | -$60.6 M | -12.1% | · | +21.8% | 6 |
| NATRNATURES SUNSHINE PRODUCTS INC | $480.1 M | $19.5 M | 4.3% | 12.1% | +4.5% | 17 |
| ARAYACCURAY INC | $401.9 M | -$49.2 M | -12.2% | -80.1% | +0.3% | 17 |
| SVASINOVAC BIOTECH LTD | $386.0 M | -$198.8 M | -51.5% | · | -5.4% | 17 |
| SNDASONIDA SENIOR LIVING, INC. | $381.1 M | -$70.8 M | -19.0% | · | -0.1% | 17 |
| PHARPharming Group N.V. | $376.1 M | $2.9 M | 0.7% | 1.1% | +12.1% | 8 |
| INGNInogen Inc | $348.7 M | -$22.7 M | -6.5% | -12.4% | +2.5% | 14 |
| CSTLCASTLE BIOSCIENCES INC | $344.2 M | -$24.2 M | -7.0% | -5.2% | +40.6% | 8 |
| TCMDTACTILE SYSTEMS TECHNOLOGY INC | $329.5 M | $19.1 M | 5.8% | 8.8% | +12.0% | 12 |
| FLGTFulgent Genetics, Inc. | $322.7 M | -$60.5 M | -19.1% | -5.4% | -5.2% | 12 |
| DCGODocGo Inc. | $322.2 M | -$182.4 M | -60.9% | -78.5% | +27.9% | 6 |
| ANGOANGIODYNAMICS INC | $320.2 M | -$36.7 M | -11.5% | -20.8% | +1.9% | 17 |
| SKINSkinHealth Systems Inc. | $300.8 M | -$9.5 M | -3.2% | -16.9% | +20.4% | 7 |
| EOLSEvolus, Inc. | $297.2 M | -$51.6 M | -17.4% | · | +39.4% | 8 |
| IRWDIRONWOOD PHARMACEUTICALS INC | $296.2 M | $24.0 M | 8.1% | · | -5.3% | 17 |
| RIGLRIGEL PHARMACEUTICALS INC | $294.3 M | $367.0 M | 124.7% | 185.9% | +22.1% | 10 |
| VMDVIEMED HEALTHCARE, INC. | $270.3 M | $14.9 M | 5.7% | 10.9% | +15.5% | 8 |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | $263.5 M | -$391.0 M | -148.4% | -55.5% | · | 13 |
| ARVNARVINAS, INC. | $262.6 M | -$80.8 M | -30.8% | -16.2% | +58.9% | 9 |
| MLABMESA LABORATORIES INC | $249.1 M | $6.7 M | 2.7% | 3.9% | +13.2% | 16 |
| VXRTVaxart, Inc. | $237.3 M | $16.3 M | · | 22.3% | +125.8% | 17 |
| KIDSORTHOPEDIATRICS CORP | $236.3 M | -$39.6 M | -16.8% | -11.3% | +27.2% | 11 |
| CERSCERUS CORP | $233.8 M | -$15.6 M | -6.7% | -26.0% | +15.4% | 17 |
| TALKTalkspace, Inc. | $228.9 M | $7.8 M | 3.4% | 6.6% | +24.6% | 7 |
| PBYIPUMA BIOTECHNOLOGY, INC. | $228.4 M | $31.1 M | 13.6% | 28.0% | +0.3% | 9 |
| VNDAVanda Pharmaceuticals Inc. | $216.1 M | -$220.5 M | -102.0% | -50.9% | -2.7% | 17 |
| AMRNAMARIN CORP PLC\UK | $213.6 M | -$38.8 M | -18.2% | -8.2% | -19.0% | 13 |
| TMCITREACE MEDICAL CONCEPTS, INC. | $212.7 M | -$59.0 M | -27.7% | -58.9% | +30.0% | 7 |
| CTKBCytek Biosciences, Inc. | $201.5 M | -$66.5 M | -33.0% | -18.0% | +16.8% | 6 |
| SRTAStrata Critical Medical, Inc. | $197.1 M | $41.3 M | 21.0% | 16.5% | +53.1% | 7 |
| LFMDLifeMD, Inc. | $194.1 M | $14.4 M | 8.0% | · | +39.1% | 14 |
| CRONCronos Group Inc. | $193.4 M | -$9.4 M | -2.0% | -0.9% | +28.9% | 9 |
| LAKELAKELAND INDUSTRIES INC | $192.6 M | -$25.3 M | -13.1% | -18.4% | +3.9% | 16 |
| BTMDbiote Corp. | $192.2 M | $27.0 M | 16.4% | · | · | 5 |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | $185.7 M | -$130.8 M | -124.2% | -48.6% | -8.1% | 7 |
| LFVNLifevantage Corp | $182.6 M | $5.1 M | · | 14.9% | -3.7% | 16 |
| KMDAKAMADA LTD | $180.5 M | $20.2 M | 11.2% | 7.6% | +6.3% | 11 |
| HURCHURCO COMPANIES INC | $178.6 M | -$15.1 M | -8.5% | -7.4% | +0.9% | 17 |
| CYRXCryoport, Inc. | $176.2 M | $78.3 M | 44.4% | 17.3% | +17.5% | 16 |
| DNAGinkgo Bioworks Holdings, Inc. | $170.2 M | -$312.8 M | -183.8% | -51.1% | +17.3% | 7 |
| PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $160.0 M | -$546.4 M | -341.5% | -213.5% | +15.2% | 17 |
| HRTXHERON THERAPEUTICS, INC. | $154.9 M | -$20.2 M | -13.0% | · | +11.8% | 10 |
| INFUInfuSystem Holdings, Inc | $143.4 M | $6.6 M | 4.6% | 11.5% | +8.1% | 17 |
| QTRXQuanterix Corp | $138.9 M | -$107.2 M | -77.1% | -34.2% | +10.0% | 10 |
| RXSTRxSight, Inc. | $134.5 M | -$38.9 M | -29.0% | -14.0% | +55.7% | 6 |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | $128.9 M | -$38.7 M | -30.0% | -612.1% | · | 16 |
| XNCRXencor Inc | $125.6 M | -$91.9 M | -73.4% | -14.0% | +0.5% | 10 |
| OMOutset Medical, Inc. | $119.5 M | -$81.7 M | -68.3% | -106.2% | +19.1% | 8 |
| GYREGYRE THERAPEUTICS, INC. | $116.6 M | $9.9 M | 8.5% | 11.7% | +41.0% | 14 |
| OSURORASURE TECHNOLOGIES INC | $115.0 M | -$68.7 M | -59.8% | -18.3% | -7.7% | 17 |
| AGENAGENUS INC | $114.2 M | -$3.1 M | -2.7% | · | +5.3% | 17 |
| INTTINTEST CORP | $113.8 M | -$2.5 M | -2.2% | -2.5% | +16.2% | 16 |
| ANIKAnika Therapeutics, Inc. | $112.8 M | -$10.9 M | -9.6% | -7.3% | -2.9% | 17 |
| GEOSGEOSPACE TECHNOLOGIES CORP | $110.8 M | -$9.7 M | -8.8% | -7.5% | +4.8% | 17 |
| SIGASIGA TECHNOLOGIES INC | $94.6 M | $23.3 M | 24.6% | 11.2% | -5.4% | 10 |
| LABSTANDARD BIOTOOLS INC. | $85.3 M | -$74.9 M | -87.8% | -16.7% | -9.2% | 17 |
| ARCTArcturus Therapeutics Holdings Inc. | $82.0 M | -$65.8 M | -80.2% | -28.9% | +53.8% | 8 |
| CTMXCytomX Therapeutics, Inc. | $76.2 M | -$17.4 M | -22.8% | · | +2.2% | 13 |
| CLLSCellectis S.A. | $72.9 M | -$67.6 M | -92.7% | -65.3% | +7.4% | 11 |
| CGENCOMPUGEN LTD | $72.8 M | $35.3 M | 48.6% | 44.8% | +105.2% | 14 |
| CHRSCoherus Oncology, Inc. | $42.2 M | $168.0 M | 398.4% | · | · | 14 |
| BWAYBrainsway Ltd. | $41.0 M | $2.9 M | 7.1% | 5.6% | +12.2% | 8 |
| VYGRVoyager Therapeutics, Inc. | $40.4 M | -$119.7 M | -296.5% | -48.3% | -25.1% | 11 |
| ALECAlector, Inc. | $21.0 M | -$142.9 M | -679.2% | -181.6% | -0.1% | 9 |
| MDWDMediWound Ltd. | $17.0 M | -$23.9 M | -140.8% | -63.9% | -4.9% | 11 |
| NNOXNano-X Imaging Ltd. | $13.0 M | -$75.0 M | · | -45.6% | · | 5 |
| ADAGAdagene Inc. | $7.7 M | -$17.6 M | · | -41.0% | +61.4% | 8 |
| PTCHFPureTech Health plc | $4.8 M | $53.5 M | 575.4% | 12.2% | -13.2% | 7 |
| AUNAAUNA S.A. | PEN 4.39 B | PEN 110.3 M | 2.8% | 7.5% | · | 3 |
| CGCCanopy Growth Corp | CAD 284.6 M | -CAD 262.9 M | -92.4% | -44.7% | -12.2% | 9 |
| VALNValneva SE | EUR 174.7 M | -EUR 115.2 M | -66.0% | · | +9.6% | 7 |
| NBTXNanobiotix S.A. | EUR 32.6 M | -EUR 24.0 M | -73.5% | · | +67.0% | 8 |
| PRQRProQR Therapeutics N.V. | EUR 15.9 M | -EUR 42.2 M | -265.2% | -61.2% | · | 5 |
| IMMPIMMUTEP Ltd | AUD 10.3 M | -AUD 61.4 M | -594.6% | -36.9% | -8.9% | 10 |
| NYXHNyxoah SA | EUR 10.0 M | -EUR 90.1 M | -899.1% | -111.0% | +170.6% | 6 |
| IVAInventiva S.A. | EUR 9.2 M | -EUR 184.2 M | · | · | +5.6% | 7 |
| IPHAInnate Pharma SA | EUR 9.0 M | -EUR 49.2 M | -546.1% | · | -33.6% | 9 |
| ACIUAC Immune SA | CHF 3.6 M | -CHF 70.4 M | · | -89.7% | · | 11 |
| NYMXFNYMOX PHARMACEUTICAL CORP | · | -$4.5 M | · | · | · | 9 |
| PRTAPROTHENA CORP PUBLIC LTD CO | · | -$244.1 M | · | -63.6% | · | 10 |
| MDLNMedline Inc. | $28.43 B | $1.16 B | 4.1% | 10.8% | · | 3 |
| UPCUniverse Pharmaceuticals INC | $17.86 B | -$3.67 B | -20.6% | -7.2% | +257.2% | 7 |
| MMEDMiniMed Group, Inc. | $3.10 B | -$333.0 M | -10.2% | -9.6% | · | 3 |
| RALRalliant Corp | $2.07 B | -$1.22 B | -59.1% | -45.3% | · | 3 |
| PIIIP3 Health Partners Inc. | $1.46 B | -$147.9 M | -22.1% | · | · | 6 |
| CRMDCorMedix Inc. | $311.7 M | $163.1 M | 52.3% | 66.6% | · | 13 |
| BLLNBillionToOne, Inc. | $305.1 M | $7.5 M | 2.4% | · | · | 3 |
| KEQUKEWAUNEE SCIENTIFIC CORP | $282.0 M | $9.6 M | 3.7% | 13.8% | +13.8% | 17 |
| OMDAOmada Health, Inc. | $260.2 M | -$12.8 M | -4.9% | · | · | 3 |
| KROSKeros Therapeutics, Inc. | $244.1 M | $87.0 M | 35.7% | 19.9% | · | 7 |
| ANABANAPTYSBIO, INC | $234.6 M | -$13.2 M | -5.6% | -24.5% | +25.6% | 11 |
| STOKStoke Therapeutics, Inc. | $184.4 M | -$6.9 M | -3.7% | -2.4% | · | 4 |
| ADAPYAdaptimmune Therapeutics PLC | $178.0 M | -$70.8 M | -39.8% | -275.7% | +175.5% | 11 |
| HTFLHeartflow, Inc. | $176.0 M | -$116.8 M | -66.3% | · | · | 3 |
| PHATPhathom Pharmaceuticals, Inc. | $175.1 M | -$221.2 M | -126.3% | · | · | 4 |
| SBCSBC Medical Group Holdings Inc | $173.6 M | $51.0 M | 29.4% | 23.0% | · | 3 |
| RGNXREGENXBIO Inc. | $170.4 M | -$193.9 M | -113.8% | -107.0% | +2.0% | 13 |
| LQDALiquidia Corp | $158.3 M | -$68.9 M | -43.5% | -111.1% | +192.5% | 7 |
| MGNXMACROGENICS INC | $149.5 M | -$74.6 M | -49.9% | -86.9% | +7.3% | 15 |
| STIMNeuronetics, Inc. | $149.2 M | -$39.0 M | -26.2% | -155.7% | +24.8% | 10 |
| ELTPELITE PHARMACEUTICALS INC | $148.9 M | $44.9 M | 30.1% | 58.9% | +42.4% | 16 |
| GRALGRAIL, Inc. | $147.2 M | -$408.4 M | -277.5% | -16.1% | · | 4 |
| KPTIKaryopharm Therapeutics Inc. | $146.1 M | -$196.0 M | -134.2% | · | +6.2% | 15 |
| NAIINATURAL ALTERNATIVES INTERNATIONAL INC | $142.5 M | -$20.7 M | -14.5% | -35.0% | -4.4% | 16 |
| XTNTXtant Medical Holdings, Inc. | $133.9 M | $5.0 M | 3.7% | 10.6% | +20.2% | 16 |
| ATRAAtara Biotherapeutics, Inc. | $120.8 M | $32.7 M | · | · | · | 4 |
| SYPRSYPRIS SOLUTIONS INC | $119.9 M | -$6.3 M | -5.3% | -33.9% | +7.8% | 16 |
| URGNUroGen Pharma Ltd. | $109.8 M | -$153.5 M | -139.8% | · | +56.2% | 10 |
| MTEXMANNATECH INC | $108.0 M | -$15.2 M | -14.1% | · | -6.5% | 19 |
| MDXHMDxHealth SA | $107.9 M | -$33.5 M | -31.1% | · | +42.3% | 7 |
| TBPHTheravance Biopharma, Inc. | $107.5 M | $105.9 M | 98.5% | 44.8% | +8.4% | 14 |
| ZVRAZEVRA THERAPEUTICS, INC. | $106.5 M | $83.2 M | 78.2% | 85.7% | +51.6% | 11 |
| ZYMEZymeworks Inc. | $106.0 M | -$81.1 M | -76.6% | -26.7% | +22.2% | 6 |
| OWLTOwlet, Inc. | $105.7 M | -$39.7 M | -37.5% | · | +7.0% | 6 |
| SMTISanara MedTech Inc. | $103.1 M | -$37.6 M | -36.4% | -165.7% | +45.9% | 16 |
| STROSUTRO BIOPHARMA, INC. | $102.5 M | -$191.1 M | -186.5% | · | +19.1% | 10 |
| NPCENeuroPace Inc | $100.0 M | -$21.5 M | -21.5% | -158.7% | +19.4% | 6 |
| BFLYButterfly Network, Inc. | $97.6 M | -$77.1 M | -79.0% | -42.2% | +16.1% | 7 |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | $95.1 M | -$131.6 M | -138.4% | -56.6% | · | 3 |
| LUNGPulmonx Corp | $90.5 M | -$54.0 M | -59.7% | -77.2% | +22.6% | 8 |
| VASOVASO Corp | $89.1 M | $1.6 M | 1.8% | 5.5% | +5.0% | 16 |
| CBLLCeribell, Inc. | $89.1 M | -$53.4 M | -60.0% | -30.8% | · | 3 |
| BDSXBIODESIX INC | $88.5 M | -$35.3 M | -39.8% | · | +14.2% | 7 |
| HBIOHARVARD BIOSCIENCE INC | $86.5 M | -$56.7 M | -65.5% | -147.1% | -3.3% | 17 |
| DCTHDELCATH SYSTEMS, INC. | $85.2 M | $2.7 M | 3.2% | 3.0% | · | 13 |
| FDMT4D Molecular Therapeutics, Inc. | $85.2 M | -$140.1 M | · | -27.6% | +44.3% | 7 |
| SPRYARS Pharmaceuticals, Inc. | $84.3 M | -$171.3 M | -203.3% | -92.3% | · | 5 |
| IRMDIRADIMED CORP | $83.8 M | $22.5 M | 26.8% | 24.8% | +21.5% | 13 |
| FTLFFITLIFE BRANDS, INC. | $81.5 M | $6.3 M | 7.8% | 15.9% | +29.8% | 16 |
| MGTXMeiraGTx Holdings plc | $81.4 M | -$114.2 M | -140.3% | · | +39.2% | 7 |
| ADCTADC Therapeutics SA | $81.4 M | -$142.6 M | -175.3% | · | · | 4 |
| TELATELA Bio, Inc. | $80.3 M | -$38.8 M | -48.4% | -223.4% | +34.5% | 9 |
| ETONEton Pharmaceuticals, Inc. | $80.0 M | -$4.6 M | -5.8% | -18.2% | +359.6% | 7 |
| PDEXPRO DEX INC | $77.5 M | $13.7 M | 0.0% | 32.4% | +15.3% | 16 |
| AUTLAutolus Therapeutics plc | $75.4 M | -$287.5 M | -381.4% | -95.0% | · | 7 |
| ELMDElectromed, Inc. | $73.8 M | $11.3 M | 15.3% | 23.3% | +15.6% | 16 |
| BCYCBICYCLE THERAPEUTICS PLC | $72.6 M | -$219.0 M | -301.7% | -31.2% | +47.5% | 9 |
| ASMBASSEMBLY BIOSCIENCES, INC. | $72.3 M | -$6.1 M | -8.5% | -5.1% | · | 10 |
| RCELAVITA Medical, Inc. | $71.6 M | -$48.6 M | -67.8% | · | · | 8 |
| FOCLEDAP TMS SA | $70.5 M | -$29.2 M | -41.5% | -94.5% | +11.1% | 17 |
| BDTXBlack Diamond Therapeutics, Inc. | $70.0 M | $22.4 M | 32.0% | 22.9% | · | 5 |
| PSNLPersonalis, Inc. | $69.6 M | -$81.3 M | -116.7% | -35.0% | -2.4% | 9 |
| RMTIROCKWELL MEDICAL, INC. | $69.3 M | -$5.3 M | -7.7% | -15.3% | +2.2% | 17 |
| KURAKura Oncology, Inc. | $67.5 M | -$278.7 M | -412.9% | -94.8% | · | 3 |
| SPROSpero Therapeutics, Inc. | $66.8 M | $8.6 M | 12.8% | 16.3% | +48.2% | 10 |
| XGNEXAGEN INC. | $66.6 M | -$20.0 M | -30.0% | -147.8% | +9.7% | 8 |
| ENTAENANTA PHARMACEUTICALS INC | $65.3 M | -$81.9 M | -125.4% | -84.6% | -11.8% | 15 |
| COSMCosmos Health Inc. | $65.3 M | -$19.1 M | -29.3% | -89.1% | +3.3% | 13 |
| FBIOFortress Biotech, Inc. | $63.3 M | $6.8 M | -52.0% | 18.8% | +6.8% | 13 |
| FEIMFREQUENCY ELECTRONICS INC | $63.2 M | -$903,000 | -1.4% | -1.6% | +3.1% | 16 |
| NUVBNuvation Bio Inc. | $62.9 M | -$204.6 M | -325.3% | -53.2% | · | 3 |
| TNGXTango Therapeutics, Inc. | $62.4 M | -$101.6 M | -162.9% | -37.2% | +52.1% | 6 |
| DERMJourney Medical Corp | $61.9 M | -$11.4 M | -18.5% | -44.0% | +6.8% | 6 |
| MHUAFMeihua International Medical | $61.8 M | $6.8 M | 11.0% | 3.9% | -7.1% | 7 |
| TRIBTRINITY BIOTECH PLC | $61.6 M | -$31.8 M | -50.7% | · | -7.4% | 10 |
| CSBRCHAMPIONS ONCOLOGY, INC. | $59.4 M | -$1.2 M | · | -30.5% | +7.7% | 16 |
| APTALPHA PRO TECH LTD | $59.1 M | $3.5 M | 6.0% | 5.7% | -10.5% | 16 |
| LNSRLENSAR, Inc. | $58.4 M | -$34.3 M | -58.7% | · | +17.2% | 7 |
| AYTUAYTU BIOPHARMA, INC | $57.6 M | -$14.3 M | -24.8% | -52.6% | -2.6% | 14 |
| MASS908 Devices Inc. | $56.2 M | $19.5 M | 34.7% | 15.1% | +15.9% | 6 |
| NKTRNEKTAR THERAPEUTICS | $55.2 M | -$164.1 M | -297.1% | -217.9% | -18.4% | 17 |
| QTTBQ32 Bio Inc. | $53.7 M | $29.8 M | 55.5% | 125.1% | · | 8 |
| APYXApyx Medical Corp | $52.8 M | -$11.2 M | -21.0% | -78.0% | +13.8% | 17 |
| PLXProtalix BioTherapeutics, Inc. | $52.7 M | -$6.6 M | -12.5% | -14.4% | -3.5% | 17 |
| IRIXIRIDEX CORP | $52.7 M | -$4.4 M | -8.4% | -126.4% | +7.7% | 17 |
| AEHRAEHR TEST SYSTEMS | $50.0 M | -$7.1 M | -14.3% | -4.2% | +24.7% | 17 |
| LXRXLEXICON PHARMACEUTICALS, INC. | $49.8 M | -$50.3 M | -101.1% | -39.7% | +15.7% | 17 |
| GOSSGossamer Bio, Inc. | $48.5 M | -$170.4 M | -351.5% | · | · | 4 |
| TLSITriSalus Life Sciences, Inc. | $45.2 M | -$39.2 M | -86.9% | · | · | 4 |
| FENCFENNEC PHARMACEUTICALS INC. | $44.6 M | -$9.7 M | -21.8% | · | · | 14 |
| AQSTAquestive Therapeutics, Inc. | $44.5 M | -$83.8 M | -188.1% | · | -0.6% | 9 |
| CPIXCUMBERLAND PHARMACEUTICALS INC | $44.5 M | -$2.8 M | -6.4% | -11.9% | +3.5% | 17 |
| SNWVSANUWAVE Health, Inc. | $44.1 M | $11.8 M | 26.8% | · | +61.1% | 16 |
| INBPINTEGRATED BIOPHARMA INC | $43.9 M | -$2.8 M | -6.5% | -15.0% | -7.1% | 16 |
| SSIISS Innovations International, Inc. | $42.5 M | -$12.1 M | -28.5% | -46.9% | · | 4 |
| OPXSOptex Systems Holdings Inc | $41.3 M | $5.1 M | 12.5% | 23.9% | +9.8% | 16 |
| KRMDKORU Medical Systems, Inc. | $41.1 M | -$2.6 M | -6.4% | -15.6% | +11.2% | 15 |
| MINDMIND TECHNOLOGY, INC | $40.9 M | $750,000 | 1.8% | 2.2% | +14.1% | 17 |
| MYOMYOMO, INC. | $40.9 M | -$15.6 M | -38.1% | -86.2% | +40.1% | 10 |
| EDITEditas Medicine, Inc. | $40.5 M | -$160.1 M | -395.0% | -198.1% | -14.9% | 10 |
| SGMOQSANGAMO THERAPEUTICS, INC | $39.6 M | -$122.9 M | -310.8% | · | -19.7% | 17 |
| IDXGINTERPACE BIOSCIENCES, INC. | $38.7 M | $24.6 M | 63.5% | · | +3.6% | 16 |
| UTMDUTAH MEDICAL PRODUCTS INC | $38.5 M | $11.3 M | 29.3% | 9.5% | -1.8% | 17 |
| RVPRETRACTABLE TECHNOLOGIES INC | $38.3 M | -$12.6 M | -32.8% | -15.6% | -14.1% | 17 |
| BGMBGM Group Ltd. | $37.9 M | -$19.9 M | -53.3% | -9.2% | -5.4% | 8 |
| CTSOCytosorbents Corp | $37.1 M | -$8.2 M | -22.1% | -96.4% | -2.0% | 15 |
| CLPTClearPoint Neuro, Inc. | $37.0 M | -$25.5 M | -69.1% | -95.6% | +23.6% | 16 |
| LIFDLFTD PARTNERS INC. | $36.9 M | -$24.9 M | -67.3% | -99.2% | +47.2% | 10 |
| SBFMSunshine Biopharma Inc. | $36.3 M | -$6.0 M | -16.5% | -25.7% | +247.7% | 16 |
| CCCCC4 Therapeutics, Inc. | $35.9 M | -$105.0 M | -292.1% | -44.4% | · | 5 |
| ETSTEarth Science Tech, Inc. | $35.7 M | $3.6 M | · | 66.9% | +202.5% | 13 |
| VRCAVerrica Pharmaceuticals Inc. | $35.6 M | -$17.9 M | -50.3% | · | · | 5 |
| SENSSenseonics Holdings, Inc. | $35.3 M | -$69.1 M | -196.0% | · | +48.1% | 11 |
| XFORX4 Pharmaceuticals, Inc | $35.1 M | -$79.2 M | -225.6% | -76.0% | · | 8 |
| DTILPRECISION BIOSCIENCES INC | $34.3 M | -$45.7 M | -133.4% | -61.5% | +7.1% | 8 |
| RPIDRAPID MICRO BIOSYSTEMS, INC. | $33.6 M | -$47.1 M | -140.3% | -86.8% | +15.9% | 6 |
| OBIOOrchestra BioMed Holdings, Inc. | $33.5 M | -$52.7 M | -157.4% | · | · | 4 |
| CWLXFC21 Investments Inc. | $32.6 M | -$3.2 M | -9.9% | -12.0% | -0.5% | 6 |
| STXSStereotaxis, Inc. | $32.4 M | -$21.6 M | -66.8% | -221.3% | +4.0% | 17 |
| ECORelectroCore, Inc. | $32.0 M | -$14.0 M | -43.6% | · | +55.7% | 9 |
| ZOMDFZomedica Corp. | $32.0 M | -$81.9 M | -255.6% | -52.6% | · | 6 |
| SONXSonendo, Inc. | $31.7 M | -$28.0 M | -88.4% | -166.8% | · | 5 |
| CCELCRYO CELL INTERNATIONAL INC | $31.6 M | -$2.4 M | -7.7% | · | +0.3% | 16 |
| POCIPRECISION OPTICS CORPORATION, INC. | $31.5 M | -$3.6 M | -11.5% | -22.3% | +24.2% | 16 |
| EYPTEyePoint, Inc. | $31.4 M | -$232.0 M | -739.4% | -72.2% | -1.8% | 17 |
| VSTMVerastem, Inc. | $30.9 M | -$209.5 M | -677.6% | · | · | 7 |
| FHTXFoghorn Therapeutics Inc. | $30.9 M | -$74.3 M | -240.3% | · | +135.1% | 6 |
| PREPrenetics Global Ltd | $30.6 M | -$46.3 M | -162.7% | -24.6% | · | 5 |
| SNYRQSynergy CHC Corp. | $30.4 M | -$12.3 M | -40.6% | · | · | 9 |
| CFORCapForce Inc. | $30.2 M | $23.6 M | 78.2% | 120.4% | +48.3% | 12 |
| BNGOBionano Genomics, Inc. | $28.5 M | -$26.4 M | -92.6% | -66.2% | +27.4% | 9 |
| AMSAMERICAN SHARED HOSPITAL SERVICES | $28.1 M | -$1.6 M | -9.7% | -6.3% | +9.5% | 17 |
| ICCCIMMUCELL CORP | $27.6 M | -$1.0 M | -3.8% | -3.8% | +12.5% | 17 |
| SRTSSensus Healthcare, Inc. | $27.5 M | -$7.7 M | -28.1% | -14.9% | +23.5% | 11 |
| CUECue Biopharma, Inc. | $27.5 M | -$26.6 M | -96.9% | -121.1% | +54.2% | 8 |
| CODACoda Octopus Group, Inc. | $26.6 M | $4.1 M | 15.5% | 7.4% | +5.8% | 12 |
| CELUCelularity Inc | $26.6 M | -$91.7 M | -345.4% | · | +13.2% | 6 |
| CYANCYANOTECH CORP | $24.2 M | -$3.2 M | -13.2% | -30.9% | -5.4% | 16 |
| PRPOPrecipio, Inc. | $24.0 M | -$363,000 | -1.5% | -2.7% | +31.6% | 17 |
| BDMDBaird Medical Investment Holdings Ltd | $22.5 M | -$27.3 M | -122.2% | -76.8% | · | 4 |
| DRIODarioHealth Corp. | $22.4 M | -$41.7 M | -186.6% | -59.6% | +24.2% | 13 |
| LFWDLifeward Ltd. | $22.0 M | -$19.9 M | 90.3% | -146.1% | +38.1% | 14 |
| DAIODATA I/O CORP | $21.5 M | -$5.2 M | -24.4% | -33.6% | +1.1% | 16 |
| CHUCCharlie's Holdings, Inc. | $20.9 M | $4.5 M | 21.5% | · | +4.6% | 16 |
| CASIFCASI Pharmaceuticals, Inc. | $20.7 M | -$48.1 M | -232.0% | · | +6.5% | 6 |
| ZJYLJin Medical International Ltd. | $20.7 M | $1.2 M | 6.7% | 4.1% | · | 5 |
| SCYXSCYNEXIS INC | $20.6 M | -$8.6 M | -41.8% | -16.5% | · | 13 |
| HKPDCellyan Biotechnology Co., Ltd | $20.3 M | -$27,056 | -0.1% | -0.6% | · | 3 |
| EVFMEvofem Biosciences, Inc. | $20.2 M | $391,000 | 1.9% | · | +114.4% | 7 |
| SNOASonoma Pharmaceuticals, Inc. | $19.5 M | -$3.2 M | -16.3% | -84.6% | +0.9% | 16 |
| SLGLSol-Gel Technologies Ltd. | $19.4 M | -$6.1 M | -31.6% | -23.7% | +17.2% | 9 |
| NEPHNEPHROS INC | $18.8 M | $1.2 M | 6.4% | 12.7% | +17.0% | 16 |
| BONBon Natural Life Ltd | $18.7 M | -$2.0 M | -11.0% | -3.9% | +0.5% | 7 |
| MRAIMarpai, Inc. | $18.1 M | -$16.6 M | -91.5% | · | · | 5 |
| BCHTBirchtech Corp. | $17.6 M | -$3.0 M | -17.2% | · | +16.7% | 16 |
| VVOSVivos Therapeutics, Inc. | $17.4 M | -$21.2 M | -121.7% | · | +5.9% | 7 |
| SEERSeer, Inc. | $16.6 M | -$73.6 M | -444.0% | -25.1% | +90.8% | 6 |
| PROFProfound Medical Corp. | $16.1 M | -$42.6 M | -264.4% | -67.1% | · | 3 |
| BTCYBIOTRICITY INC. | $16.0 M | -$2.4 M | -15.0% | · | +36.4% | 8 |
| VSEEVSEE HEALTH, INC. | $14.6 M | -$14.7 M | -100.6% | · | · | 3 |
| LCTXLineage Cell Therapeutics, Inc. | $14.6 M | -$63.5 M | -435.3% | -103.4% | +51.5% | 17 |
| IRDOpus Genetics, Inc. | $14.2 M | -$49.6 M | -349.3% | -449.4% | · | 12 |
| ABUSArbutus Biopharma Corp | $14.1 M | -$33.5 M | -237.9% | -38.5% | +15.3% | 17 |
| CVSICV Sciences, Inc. | $13.8 M | -$958,000 | -6.9% | -58.7% | -10.8% | 14 |
| AATCAUTOSCOPE TECHNOLOGIES CORP | $13.2 M | $2.3 M | 17.3% | 11.7% | -1.3% | 13 |
| PTNPALATIN TECHNOLOGIES INC | $13.2 M | -$8.4 M | · | · | · | 16 |
| TNXPTonix Pharmaceuticals Holding Corp. | $13.1 M | -$124.0 M | -946.2% | -64.5% | · | 3 |
| INISRADNOSTIX INC | $13.1 M | -$908,002 | -6.9% | -22.6% | +6.9% | 12 |
| ESMCESCALON MEDICAL CORP | $12.7 M | $4.0 M | 31.5% | 102.3% | +4.0% | 16 |
| EMMAEmmaus Life Sciences, Inc. | $12.5 M | -$7.5 M | -60.2% | · | -11.7% | 15 |
| CDIXCardiff Lexington Corp | $11.5 M | -$5.5 M | -47.7% | · | +27.3% | 16 |
| JAGXJaguar Health, Inc. | $11.5 M | -$53.6 M | -469.1% | · | +4.2% | 12 |
| LGMKLogicMark, Inc. | $11.4 M | -$7.5 M | -65.4% | -56.0% | -0.0% | 13 |
| CBIOCRESCENT BIOPHARMA, INC. | $10.8 M | -$153.9 M | -1419.6% | · | · | 10 |
| ELSEELECTRO SENSORS INC | $10.1 M | $306,000 | 3.0% | 2.1% | +5.9% | 16 |
| WOKWORK Medical Technology Group LTD | $9.8 M | -$1.1 M | -12.2% | -6.8% | · | 4 |
| TSHATaysha Gene Therapies, Inc. | $9.8 M | -$109.0 M | -1115.3% | -68.5% | · | 4 |
| MDNCMedinotec Inc. | $9.7 M | $794,502 | 8.2% | 15.9% | · | 4 |
| PGENPRECIGEN, INC. | $9.7 M | -$250.6 M | · | -843.6% | -21.3% | 15 |
| CRISCURIS INC | $9.4 M | -$7.6 M | -80.3% | · | -2.7% | 17 |
| AWHLAspira Women's Health Inc. | $9.2 M | -$12.8 M | -138.7% | · | +14.7% | 16 |
| ISCOInternational Stem Cell CORP | $9.1 M | -$418,000 | -4.6% | · | +5.0% | 16 |
| NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | $9.1 M | -$3.6 M | -39.6% | -91.3% | · | 12 |
| LCTCLifeloc Technologies, Inc | $9.0 M | -$2.5 M | -27.4% | -47.8% | +7.3% | 16 |
| NSPRInspireMD, Inc. | $9.0 M | -$48.8 M | -543.3% | -106.9% | +29.3% | 16 |
| MLSSMILESTONE SCIENTIFIC INC. | $9.0 M | -$5.7 M | -63.8% | -132.4% | +10.5% | 16 |
| NNNNAnbio Biotechnology | $8.6 M | $6.4 M | 74.1% | 27.0% | · | 4 |
| NUWENuwellis, Inc. | $8.3 M | -$17.5 M | -211.9% | -382.9% | +2.1% | 14 |
| RDHLRedHill Biopharma Ltd. | $8.0 M | -$8.3 M | -102.8% | · | +5.0% | 10 |
| ACRSAclaris Therapeutics, Inc. | $7.8 M | -$64.9 M | -829.6% | -50.2% | +3.8% | 9 |
| XAIRBeyond Air, Inc. | $7.7 M | -$33.2 M | -447.1% | -337.4% | · | 6 |
| EVAXEvaxion A/S | $7.5 M | -$7.7 M | -102.4% | · | · | 4 |
| OVIDOvid Therapeutics Inc. | $7.3 M | -$17.4 M | -240.1% | -17.5% | -10.5% | 6 |
| WHWKWhitehawk Therapeutics, Inc. | $7.1 M | -$20.6 M | -288.3% | -21.8% | -12.6% | 8 |
| IVFINVO Fertility, Inc. | $6.8 M | -$23.3 M | -340.9% | -235.5% | +45.8% | 15 |
| EUDAEUDA Health Holdings Ltd | $6.8 M | -$2.8 M | -40.6% | · | · | 5 |
| PFHOPACIFIC HEALTH CARE ORGANIZATION INC | $6.7 M | $1.4 M | 20.7% | 11.2% | +2.1% | 16 |
| FATEFATE THERAPEUTICS INC | $6.6 M | -$136.3 M | · | -51.8% | -26.7% | 14 |
| ECIAENCISION INC | $6.6 M | -$220,198 | -3.4% | -12.7% | -3.1% | 15 |
| KYNBKYNTRA BIO, INC. | $6.4 M | $183.5 M | · | · | · | 13 |
| KRROKorro Bio, Inc. | $6.4 M | -$117.3 M | · | -110.7% | · | 7 |
| ABEOABEONA THERAPEUTICS INC. | $5.8 M | $71.2 M | 1223.1% | 70.0% | · | 14 |
| DBVTDBV Technologies S.A. | $5.6 M | -$146.9 M | · | -149.8% | -13.0% | 7 |
| MSAIMultiSensor AI Holdings, Inc. | $5.6 M | -$11.7 M | -211.0% | -52.9% | · | 4 |
| CLIRClearSign Technologies Corp | $5.2 M | -$5.5 M | -105.0% | -47.2% | · | 12 |
| CNSYCERENOME, INC. | $5.2 M | -$22.4 M | -429.4% | · | · | 13 |
| ZEOXZeo ScientifiX, Inc. | $5.2 M | -$5.5 M | · | · | +11.2% | 15 |
| ENSCEnsysce Biosciences, Inc. | $5.1 M | -$10.2 M | -200.8% | · | +5.2% | 6 |
| SCNDSCIENTIFIC INDUSTRIES INC | $5.1 M | -$1.2 M | -35.2% | -12.3% | · | 15 |
| PCYNPROCYON CORP | $5.0 M | -$341,140 | -6.8% | -13.9% | +3.5% | 14 |
| MCTACharming Medical Ltd | $4.8 M | -$22,648 | -0.5% | -0.9% | · | 3 |
| PRMEPrime Medicine, Inc. | $4.6 M | -$201.1 M | · | -146.8% | · | 6 |
| NNNEXTNAV INC. | $4.6 M | -$189.3 M | · | · | +51.7% | 6 |
| HYEXHEALTHY EXTRACTS INC. | $4.5 M | -$881,119 | -19.5% | -7.2% | +28.3% | 11 |
| BMRABIOMERICA INC | $4.5 M | -$3.8 M | -84.8% | -112.1% | -9.2% | 16 |
| OCGNOcugen, Inc. | $4.4 M | -$67.8 M | · | · | · | 12 |
| PRPHProPhase Labs, Inc. | $4.3 M | -$14.7 M | -339.3% | -271.5% | -21.4% | 17 |
| INBSINTELLIGENT BIO SOLUTIONS INC. | $4.2 M | -$12.4 M | -295.8% | -292.3% | +16.3% | 7 |
| CPHICHINA PHARMA HOLDINGS, INC. | $4.1 M | -$3.2 M | -76.9% | -20.9% | -17.5% | 16 |
| IMDXInsight Molecular Diagnostics Inc. | $4.1 M | -$50.2 M | -1238.5% | · | · | 6 |
| CRVOCervoMed Inc. | $4.0 M | -$27.0 M | -673.1% | -93.9% | · | 8 |
| CBDYTarget Group Inc. | $3.9 M | -$1.4 M | -35.0% | · | · | 11 |
| RADXRadiopharm Theranostics Ltd | $3.6 M | -$38.3 M | -1055.3% | -109.2% | · | 3 |
| MRKRMarker Therapeutics, Inc. | $3.5 M | -$12.2 M | -343.0% | -68.8% | +48.0% | 9 |
| SRZNSurrozen, Inc. | $3.5 M | -$242.0 M | · | · | · | 5 |
| JRSSJRSIS HEALTH CARE Corp | $3.5 M | -$80,912 | -2.7% | · | -34.4% | 11 |
| ICCMIceCure Medical Ltd. | $3.4 M | -$15.1 M | -445.6% | -188.8% | -2.7% | 7 |
| ADMTADM TRONICS UNLIMITED, INC. | $3.3 M | -$100,374 | -3.0% | -16.2% | +1.6% | 16 |
| AURXNuo Therapeutics, Inc. | $3.3 M | -$2.5 M | -75.8% | · | · | 15 |
| DYAIDYADIC INTERNATIONAL INC | $3.1 M | -$7.4 M | -238.3% | -397.8% | +14.0% | 9 |
| TXMDTherapeuticsMD, Inc. | $3.0 M | -$569,000 | -18.8% | -2.1% | · | 15 |
| XBIOXenetic Biosciences, Inc. | $3.0 M | -$2.7 M | -90.1% | -40.0% | +46.8% | 14 |
| STEKStemtech Corp | $2.9 M | -$4.0 M | -140.8% | · | -8.1% | 6 |
| HCILHongchang International Co., Ltd | $2.9 M | -$472,393 | -16.5% | · | +77.3% | 12 |
| RNACCartesian Therapeutics, Inc. | $2.8 M | -$130.3 M | · | · | -30.0% | 12 |
| TRAWTraws Pharma, Inc. | $2.8 M | $9.2 M | 328.7% | · | +64.6% | 15 |
| USAQQHSLab, Inc. | $2.7 M | $457,417 | 17.0% | · | +84.9% | 12 |
| FEEDENvue Medical, Inc. | $2.6 M | -$18.2 M | -712.3% | -106.6% | +32.6% | 12 |
| GOVXGeoVax Labs, Inc. | $2.5 M | -$21.5 M | -862.3% | -483.8% | · | 10 |
| QSIQuantum-Si Inc | $2.4 M | -$101.3 M | · | -46.5% | · | 5 |
| CLGNCollPlant Biotechnologies Ltd | $2.4 M | -$11.5 M | -484.6% | -117.6% | -17.3% | 8 |
| FEMYFEMASYS INC | $2.3 M | -$18.6 M | -812.3% | -455.8% | +17.2% | 6 |
| UCLEUS NUCLEAR CORP. | $2.2 M | -$1.2 M | -57.1% | · | +4.4% | 14 |
| NASCCan B Corp | $2.2 M | -$9.7 M | -451.7% | · | +26.4% | 9 |
| KRSAKorsana Biosciences, Inc. | $2.1 M | -$3.5 M | -170.1% | -39.3% | · | 7 |
| HLYKHealthLynked Corp | $2.1 M | -$3.3 M | -158.8% | · | -19.6% | 10 |
| DNTHDianthus Therapeutics, Inc. | $2.0 M | -$162.3 M | · | -38.4% | · | 7 |
| ORMPORAMED PHARMACEUTICALS INC. | $2.0 M | $64.0 M | · | 37.0% | · | 9 |
| LPCNLipocine Inc. | $2.0 M | -$9.6 M | -487.1% | -54.3% | · | 12 |
| BIOEBio Essence Corp | $1.9 M | $896,197 | · | · | +14.6% | 6 |
| VYCOVYCOR MEDICAL INC | $1.9 M | -$72,426 | -3.9% | · | +10.3% | 16 |
| LDDDLongduoduo Co Ltd | $1.8 M | -$578,631 | -35.2% | -61.3% | +34.5% | 6 |
| VNRXVOLITIONRX LTD | $1.7 M | -$23.4 M | -1360.6% | · | +164.1% | 9 |
| RANIRani Therapeutics Holdings, Inc. | $1.6 M | -$29.7 M | · | -169.6% | · | 6 |
| ATPCAgape ATP Corp | $1.5 M | -$2.3 M | -151.4% | -18.7% | -15.1% | 9 |
| NRXPNRX Pharmaceuticals, Inc. | $1.4 M | -$28.6 M | · | · | · | 3 |
| OTLKOutlook Therapeutics, Inc. | $1.4 M | -$62.4 M | · | · | · | 6 |
| ATXIAVENUE THERAPEUTICS, INC. | $1.4 M | -$2.9 M | -209.9% | -125.7% | · | 2 |
| NWBONORTHWEST BIOTHERAPEUTICS INC | $1.4 M | -$60.2 M | · | · | +1.3% | 16 |
| CPMDCANNAPHARMARX, INC. | $1.4 M | -$11.1 M | -817.2% | · | · | 13 |
| EMEDElectromedical Technologies, Inc | $1.3 M | -$2.6 M | -195.8% | · | · | 5 |
| SPRCSciSparc Ltd. | $1.3 M | -$6.3 M | -572.1% | -79.7% | · | 3 |
| IGCIGC Pharma, Inc. | $1.3 M | -$7.1 M | -560.3% | -104.3% | -20.8% | 15 |
| VTGNVistagen Therapeutics, Inc. | $1.3 M | -$69.7 M | · | -131.6% | +3.1% | 13 |
| RAJAFTFA Therapeutics, Inc. | $1.2 M | -$154,822 | -12.4% | · | · | 5 |
| BLRXBioLineRx Ltd. | $1.2 M | -$2.0 M | -171.7% | · | · | 5 |
| SXTCChina SXT Pharmaceuticals, Inc. | $1.1 M | -$6.2 M | -545.2% | -27.5% | -24.9% | 10 |
| RSCFREFLECT SCIENTIFIC, INC. | $1.1 M | -$459,028 | -42.5% | -21.9% | -7.0% | 14 |
| DAREDare Bioscience, Inc. | $1.0 M | -$13.4 M | · | · | · | 9 |
| EHSIElite Health Systems Inc. | $1.0 M | -$7.8 M | -762.1% | -164.5% | · | 9 |
| SINTSintx Technologies, Inc. | $1.0 M | -$10.4 M | -1018.1% | -303.8% | +11.4% | 13 |
| PLURPluri Inc. | $1.0 M | -$23.8 M | · | · | · | 13 |
| STTKShattuck Labs, Inc. | $1.0 M | -$48.8 M | · | -60.3% | -36.8% | 7 |
| RFLRafael Holdings, Inc. | $917,000 | -$30.5 M | · | -34.6% | · | 10 |
| ASTCASTROTECH Corp | $913,000 | -$14.4 M | · | -75.4% | +22.3% | 16 |
| VJETFlyte Aviation, Inc. | $819,000 | -$17.2 M | · | -182.7% | +25.9% | 9 |
| IMAImageneBio, Inc. | $800,000 | -$45.3 M | · | · | -38.6% | 6 |
| BICXBioCorRx Inc. | $797,244 | -$3.4 M | · | · | +45.4% | 16 |
| MCRBSeres Therapeutics, Inc. | $789,000 | $5.7 M | 721.9% | 19.6% | · | 11 |
| GTHPGUIDED THERAPEUTICS INC | $767,000 | -$3.2 M | · | · | +49.7% | 16 |
| LEXXLexaria Bioscience Corp. | $705,923 | -$11.9 M | · | -215.9% | +17.5% | 14 |
| HRGNHarvard Apparatus Regenerative | $704,000 | -$6.9 M | -975.7% | -321.1% | · | 13 |
| PMHSPolomar Health Services, Inc. | $648,231 | -$10.7 M | · | · | · | 4 |
| BTAIQBioXcel Therapeutics, Inc. | $642,000 | -$69.9 M | · | · | · | 4 |
| CODXCo-Diagnostics, Inc. | $622,489 | -$46.9 M | · | -125.9% | -61.6% | 9 |
| VCNXVACCINEX, INC. | $601,000 | -$18.6 M | · | · | +2.8% | 8 |
| YDESYD Bio Ltd | $596,817 | -$8.3 M | -1392.6% | · | · | 3 |
| CRDFCardiff Oncology, Inc. | $593,000 | -$45.9 M | · | -71.5% | +10.1% | 15 |
| YARWYarrow Bioscience, Inc. | $570,000 | -$26.5 M | · | -66.3% | -51.4% | 10 |
| SLNSilence Therapeutics plc | $559,000 | -$88.6 M | · | -90.3% | · | 4 |
| ITOCiTonic Holdings Ltd | $523,031 | -$5.1 M | -974.8% | -82.8% | · | 4 |
| AERGAPPLIED ENERGETICS, INC. | $461,727 | -$14.9 M | · | -374.0% | · | 5 |
| POSCPOSITRON CORP | $461,452 | -$10.6 M | · | · | · | 7 |
| SCNXScienture Holdings, Inc. | $431,609 | -$41.5 M | · | -55.6% | · | 13 |
| MNOVMEDICINOVA INC | $409,657 | -$12.0 M | · | -25.5% | · | 5 |
| CANFCan-Fite BioPharma Ltd. | $405,000 | -$9.8 M | · | -178.2% | -11.9% | 8 |
| AAGHAmerica Great Health | $391,743 | -$719,119 | -184.1% | · | +134.9% | 13 |
| BRTXBioRestorative Therapies, Inc. | $359,700 | -$14.2 M | · | -320.5% | · | 13 |
| PLSEPULSE BIOSCIENCES, INC. | $350,000 | -$72.8 M | · | -74.4% | · | 6 |
| PVCTPROVECTUS BIOPHARMACEUTICALS, INC. | $336,108 | -$5.4 M | · | · | · | 9 |
| CFOOChina Foods Holdings Ltd. | $327,871 | -$398,672 | -121.6% | · | -20.2% | 16 |
| ABVCABVC BIOPHARMA, INC. | $296,000 | -$7.9 M | · | -128.2% | -9.3% | 14 |
| QTEXQTREX Quantum Ltd. | $289,000 | -$13.2 M | · | -397.9% | · | 3 |
| NPHCNUTRA PHARMA CORP | $257,612 | -$2.0 M | -794.8% | · | +37.8% | 16 |
| FCUVFOCUS UNIVERSAL INC. | $255,023 | -$4.8 M | · | -166.0% | -31.4% | 12 |
| QURTQuarta-Rad, Inc. | $244,955 | -$256,929 | -104.9% | -170.8% | -22.2% | 11 |
| RGBPRegen BioPharma Inc | $236,561 | -$1.3 M | -538.8% | · | +16.5% | 12 |
| CLNNClene Inc. | $200,000 | -$26.2 M | · | · | -0.6% | 6 |
| ATYRaTYR PHARMA INC | $190,000 | -$74.1 M | · | -107.8% | · | 7 |
| LSTALISATA THERAPEUTICS, INC. | $170,000 | -$16.6 M | · | -74.7% | · | 11 |
| ZIVOZivo Bioscience, Inc. | $157,220 | -$13.4 M | · | · | · | 14 |
| ENDVENDONOVO THERAPEUTICS, INC. | $135,355 | -$18.5 M | · | · | · | 11 |
| VIVSVivoSim Labs, INC. | $131,000 | -$13.8 M | · | · | · | 15 |
| SERSerina Therapeutics, Inc. | $130,000 | -$19.2 M | · | · | -18.5% | 9 |
| IBIOiBio, Inc. | $100,000 | -$33.0 M | · | -65.7% | · | 16 |
| ATNMActinium Pharmaceuticals, Inc. | $90,000 | -$33.9 M | · | -167.0% | · | 6 |
| AIMAIM ImmunoTech Inc. | $88,000 | -$14.0 M | · | · | -11.6% | 17 |
| ACONAclarion, Inc. | $75,730 | -$7.2 M | · | -104.8% | · | 5 |
| SILOSilo Pharma, Inc. | $72,102 | -$4.2 M | · | -74.6% | · | 6 |
| PAVMPAVmed Inc. | $71,000 | $401,000 | · | · | · | 5 |
| NTRRNEUTRA CORP. | $67,996 | -$561,417 | -825.7% | · | · | 4 |
| INOINOVIO PHARMACEUTICALS, INC. | $65,343 | -$84.9 M | · | -183.5% | -61.2% | 17 |
| AVTXAvalo Therapeutics, Inc. | $59,000 | -$78.3 M | · | -72.4% | -61.2% | 11 |
| LNAILunai Bioworks Inc. | $51,992 | -$3.6 M | · | · | · | 5 |
| INMBInmune Bio, Inc. | $50,000 | -$45.9 M | · | -165.2% | +35.4% | 8 |
| ENTXEntera Bio Ltd. | $42,000 | -$11.4 M | · | -108.0% | · | 6 |
| ALTAltimmune, Inc. | $41,000 | -$88.1 M | · | -50.6% | -65.3% | 12 |
| AXIMAXIM BIOTECHNOLOGIES, INC. | $39,518 | -$8.1 M | · | · | · | 13 |
| LYELLyell Immunopharma, Inc. | $36,000 | -$274.4 M | · | -87.0% | -65.9% | 7 |
| TLPHTALPHERA, INC. | $28,000 | -$14.3 M | · | -114.2% | · | 15 |
| CKDXFOpthea Ltd | $25,000 | -$162.8 M | · | · | -15.8% | 7 |
| SKVISKINVISIBLE, INC. | $20,000 | -$1.1 M | · | · | -33.4% | 16 |
| BDPTBIOADAPTIVES, INC. | $18,278 | -$1.6 M | · | · | +2.3% | 7 |
| PRFXPRF Technologies Ltd. | $17,000 | -$5.0 M | · | -96.9% | · | 3 |
| YBGJYubo International Biotech Ltd | $12,353 | -$1.1 M | · | · | · | 14 |
| GNLXGENELUX Corp | $8,000 | -$32.1 M | · | -170.0% | · | 4 |
| VRAXVirax Biolabs Group Ltd | $6,331 | -$6.1 M | · | -109.6% | · | 5 |
| CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, | $6,000 | -$6.0 M | · | -86.5% | -48.4% | 16 |
| TCRTAlaunos Therapeutics, Inc. | $5,000 | -$4.2 M | · | -198.1% | · | 11 |
| OWPCOne World Products, Inc. | $4,863 | -$3.9 M | · | · | · | 5 |
| ADTXAditxt, Inc. | $3,195 | -$43.1 M | · | -1183.4% | · | 5 |
| AIBTAIBOTICS, INC. | $2,183 | -$2.2 M | · | · | · | 5 |
| ALLOAllogene Therapeutics, Inc. | $0 | -$190.9 M | · | -53.4% | · | 7 |
| AMLXAmylyx Pharmaceuticals, Inc. | $0 | -$144.7 M | · | -61.6% | · | 5 |
| ANVSAnnovis Bio, Inc. | $0 | -$28.9 M | · | -220.6% | · | 6 |
| APLMApollomics Inc. | $0 | -$53.9 M | · | -233.7% | · | 5 |
| APTOFAptose Biosciences Inc. | $0 | -$25.5 M | · | · | · | 6 |
| BCDABioCardia, Inc. | $0 | -$8.2 M | · | -950.1% | · | 13 |
| BYSIBeyondSpring Inc. | $0 | -$1.0 M | · | · | · | 12 |
| BZYRBURZYNSKI RESEARCH INSTITUTE INC | $0 | -$1.4 M | · | · | · | 13 |
| CAPRCAPRICOR THERAPEUTICS, INC. | $0 | -$105.0 M | · | -46.6% | · | 15 |
| CMPXCompass Therapeutics, Inc. | $0 | -$66.5 M | · | -41.3% | · | 3 |
| DSGNDesign Therapeutics, Inc. | $0 | -$69.8 M | · | -30.7% | · | 3 |
| EDGMEdgemode, Inc. | $0 | -$24.6 M | · | · | · | 9 |
| ELOXEloxx Pharmaceuticals, Inc. | $0 | -$6.0 M | · | · | · | 7 |
| FULCFulcrum Therapeutics, Inc. | $0 | -$74.9 M | · | -25.3% | · | 6 |
| HSTCHST Global, Inc. | $0 | -$146,210 | · | · | · | 7 |
| HURATuHURA Biosciences, Inc. | $0 | -$30.1 M | · | -169.2% | · | 5 |
| HWKEHawkeye Digital, Inc. | $0 | -$572,893 | · | · | · | 8 |
| IXHLIncannex Healthcare Inc. | $0 | -$19.3 M | · | -47.8% | · | 3 |
| KALAKALA BIO, Inc. | $0 | -$27.0 M | · | -279.2% | · | 10 |
| KPRXKIORA PHARMACEUTICALS INC | $0 | -$10.8 M | · | -51.7% | · | 10 |
| MBRXMoleculin Biotech, Inc. | $0 | -$33.6 M | · | -256.0% | · | 10 |
| MNPRMonopar Therapeutics | $0 | -$13.7 M | · | -14.2% | · | 6 |
| NGNENeurogene Inc. | $0 | -$90.4 M | · | -31.4% | · | 4 |
| NKTXNkarta, Inc. | $0 | -$104.1 M | · | -28.9% | · | 3 |
| NNVCNANOVIRICIDES, INC. | $0 | -$8.2 M | · | -101.5% | · | 4 |
| PALIPALISADE BIO, INC. | $0 | -$16.8 M | · | -24.5% | · | 15 |
| PLRXPLIANT THERAPEUTICS, INC. | $0 | -$149.3 M | · | -61.5% | · | 7 |
| PMCBPharmaCyte Biotech, Inc. | $0 | -$19.4 M | · | -45.6% | · | 16 |
| PTIXProtagenic Therapeutics, Inc.\new | $0 | $1.4 M | · | · | · | 9 |
| RCKTROCKET PHARMACEUTICALS, INC. | $0 | -$223.1 M | · | -60.3% | · | 10 |
| RNTXRein Therapeutics, Inc. | $0 | -$49.9 M | · | -139.9% | · | 11 |
| SPRBSPRUCE BIOSCIENCES, INC. | $0 | -$39.0 M | · | -109.2% | · | 4 |
| SRRKScholar Rock Holding Corp | $0 | -$377.9 M | · | -123.1% | · | 6 |
| SYBXSYNLOGIC, INC. | $0 | -$1.0 M | · | -8.2% | · | 10 |
| TCRGCannaisseur Group Inc. | $0 | -$1.8 M | · | · | · | 4 |
| TENXTENAX THERAPEUTICS, INC. | $0 | -$52.6 M | · | -55.6% | · | 8 |
| UEECUnited Health Products, Inc. | $0 | -$2.7 M | · | · | · | 14 |
| VANIVivani Medical, Inc. | $0 | -$26.6 M | · | -159.6% | · | 9 |
| VTVTvTv Therapeutics Inc. | $0 | -$27.0 M | · | -70.4% | · | 13 |
| XCUREXICURE, INC. | $0 | -$4.9 M | · | -92.5% | · | 10 |
| ZNTLZentalis Pharmaceuticals, Inc. | $0 | -$137.1 M | · | -49.5% | · | 4 |
| AAPGASCENTAGE PHARMA GROUP INTERNATIONAL | CNY 980.6 M | -CNY 405.4 M | -41.4% | -249.8% | · | 3 |
| PAIYYAesthetic Medical International | CNY 755.7 M | -CNY 19.9 M | -3.3% | -50.3% | -2.8% | 8 |
| BNRBurning Rock Biotech Ltd | CNY 539.6 M | -CNY 55.3 M | -10.3% | -9.9% | +4.6% | 8 |
| CCMConcord Medical Services Holdings Ltd | CNY 460.5 M | -CNY 92.8 M | -82.4% | · | +15.6% | 17 |
| INCRIntercure Ltd. | ILS 238.8 M | -ILS 67.8 M | -30.5% | -15.9% | +93.0% | 6 |
| ZYBTZhengye Biotechnology Holding Ltd | CNY 116.4 M | -CNY 69.8 M | -71.3% | -26.1% | · | 4 |
| IMCCIM Cannabis Corp. | CAD 54.7 M | -CAD 11.3 M | -21.5% | · | +28.1% | 7 |
| PLSMPulsenmore Ltd. | ILS 40.0 M | -ILS 15.9 M | -39.6% | -17.6% | · | 3 |
| HYFTMindWalk Holdings Corp. | CAD 24.5 M | -CAD 30.2 M | -123.3% | -102.0% | +11.8% | 6 |
| MCUJFMEDICURE INC | CAD 21.9 M | -CAD 1.0 M | -4.7% | -5.1% | +1.7% | 10 |
| XTXXFAdastra Holdings Ltd. | CAD 13.3 M | -CAD 4.3 M | -32.2% | -21.1% | · | 3 |
| IMRNImmuron Ltd | AUD 7.3 M | -AUD 5.2 M | -71.6% | -50.2% | +23.7% | 10 |
| MMTZFMindMaze Therapeutics Holding SA | CHF 6.3 M | -CHF 98.2 M | · | -99.4% | · | 3 |
| AVCRFAvricore Health Inc. | CAD 4.7 M | -CAD 668,977 | -14.4% | -33.6% | · | 9 |
| ADXNAddex Therapeutics Ltd. | CHF 404,102 | CHF 7.1 M | · | 130.4% | -31.9% | 7 |
| GELSGelteq Ltd | AUD 165,645 | -$6.6 M | · | -43.0% | · | 2 |
| POASPHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd | SGD 132,077 | -SGD 6.2 M | · | · | · | 3 |
| KZIAKAZIA THERAPEUTICS LTD | AUD 42,000 | -AUD 20.7 M | · | · | · | 8 |
| IFRXInflaRx N.V. | EUR 29,331 | -EUR 45.6 M | · | · | · | 3 |
| ABPOAbpro Holdings, Inc. | · | -$2.9 M | · | · | · | 2 |
| AEMDAETHLON MEDICAL INC | · | -$7.2 M | · | -142.9% | · | 13 |
| AGTXAgentix Corp. | · | -$485,636 | · | · | · | 5 |
| ALGSAligos Therapeutics, Inc. | · | -$24.2 M | · | · | · | 5 |
| ALXOALX ONCOLOGY HOLDINGS INC | · | -$101.7 M | · | -145.7% | · | 5 |
| ANIXAnixa Biosciences Inc | · | -$10.9 M | · | -62.2% | · | 13 |
| APVOAptevo Therapeutics Inc. | · | -$26.0 M | · | -234.6% | · | 8 |
| ATHEALTERITY THERAPEUTICS LTD | · | -AUD 12.1 M | · | · | · | 3 |
| ATOSATOSSA THERAPEUTICS, INC. | · | -$34.8 M | · | -62.7% | · | 5 |
| AURAAura Biosciences, Inc. | · | -$106.2 M | · | -73.5% | · | 0 |
| BCABBioAtla, Inc. | · | -$59.6 M | · | · | · | 1 |
| BDRXBiodexa Pharmaceuticals Plc | · | -GBP 6.4 M | · | -64.7% | · | 9 |
| BETRFBetterLife Pharma Inc. | · | -CAD 9.1 M | · | · | · | 0 |
| BIVIBIOVIE INC. | · | -$22.1 M | · | -150.8% | · | 0 |
| BIXTBIOXYTRAN, INC | · | -$2.1 M | · | · | · | 8 |
| BNTCBenitec Biopharma Inc. | · | -$45.5 M | · | -33.2% | · | 6 |
| BPTHBIO-PATH HOLDINGS, INC. | · | -$9.9 M | · | -3325.7% | · | 8 |
| CABACabaletta Bio, Inc. | · | -$167.9 M | · | -127.0% | · | 0 |
| CATXPerspective Therapeutics, Inc. | · | -$103.1 M | · | -41.4% | · | 14 |
| CGEMCullinan Therapeutics, Inc. | · | -$219.9 M | · | -44.0% | · | 3 |
| CMNDClearmind Medicine Inc. | · | -$3.9 M | · | -179.4% | · | 0 |
| COCPCocrystal Pharma, Inc. | · | -$8.8 M | · | -111.4% | · | 3 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | · | -$78.5 M | · | -54.2% | · | 8 |
| CTXRCitius Pharmaceuticals, Inc. | · | -$39.7 M | · | -57.8% | · | 10 |
| CVMCEL SCI CORP | · | -$25.4 M | · | -176.3% | · | 4 |
| CYDYCytoDyn Inc. | · | -$42.7 M | · | · | · | 3 |
| CYTOFAltamira Therapeutics Ltd. | · | -$8.5 M | · | · | · | 3 |
| DCOYDecoy Therapeutics Inc. | · | -$12.5 M | · | -338.3% | · | 8 |
| DMRADamora Therapeutics, Inc. | · | -$209.8 M | · | -163.8% | · | 0 |
| EDSAEdesa Biotech, Inc. | · | -$7.2 M | · | -99.6% | · | 9 |
| ELDNEledon Pharmaceuticals, Inc. | · | -$45.6 M | · | -63.6% | · | 5 |
| ELVNEnliven Therapeutics, Inc. | · | -$103.7 M | · | -27.0% | · | 0 |
| ENGNenGene Therapeutics Inc. | · | -$117.3 M | · | -53.3% | · | 0 |
| ENVBEnveric Biosciences, Inc. | · | -$8.8 M | · | -304.0% | · | 5 |
| EOCNGalmed Pharmaceuticals Ltd. | · | -$10.3 M | · | -64.2% | · | 7 |
| EQEquillium, Inc. | · | -$22.4 M | · | -94.0% | · | 3 |
| ERNAErnexa Therapeutics Inc. | · | -$14.1 M | · | -686.7% | · | 14 |
| FBRXForte Biosciences, Inc. | · | -$69.4 M | · | -122.3% | · | 4 |
| FLNAFILANA THERAPEUTICS, INC. | · | -$91.0 M | · | -82.7% | · | 5 |
| GCTKGlucotrack, Inc. | · | -$19.4 M | · | · | · | 6 |
| GNPXGenprex, Inc. | · | -$16.2 M | · | -338.7% | · | 8 |
| GTBPGT Biopharma, Inc. | · | -$28.4 M | · | · | · | 10 |
| HEPAHepion Pharmaceuticals, Inc. | · | -$8.3 M | · | · | · | 4 |
| IKTInhibikase Therapeutics, Inc. | · | -$48.3 M | · | -36.0% | · | 3 |
| IMNNImunon, Inc. | · | -$14.5 M | · | -256.4% | · | 6 |
| IMRXImmuneering Corp | · | -$56.0 M | · | -43.1% | · | 4 |
| INMInMed Pharmaceuticals Inc. | · | -$12.6 M | · | -173.1% | · | 5 |
| INTIInhibitor Therapeutics, Inc. | · | -$3.3 M | · | · | · | 9 |
| LITSLite Strategy, Inc. | · | -$71.2 M | · | -243.0% | · | 9 |
| LRMRLarimar Therapeutics, Inc. | · | -$165.7 M | · | -132.6% | · | 8 |
| MBIOMUSTANG BIO, INC. | · | -$1.9 M | · | · | · | 3 |
| MBOTMicrobot Medical Inc. | · | -$13.1 M | · | -32.4% | · | 7 |
| MODDModular Medical, Inc. | · | -$28.2 M | · | -188.1% | · | 8 |
| MOLNMOLECULAR PARTNERS AG | CHF 0 | -CHF 61.7 M | · | -55.5% | · | 7 |
| MTNBMatinas BioPharma Holdings, Inc. | · | -$10.3 M | · | -166.6% | · | 10 |
| NBPNovaBridge Biosciences | · | -$46.3 M | · | -21.4% | · | 7 |
| NDRAENDRA Life Sciences Inc. | · | -$7.0 M | · | -291.6% | · | 5 |
| NERVMinerva Neurosciences, Inc. | · | -$293.4 M | · | · | · | 8 |
| NIKANIKA PHARMACEUTICALS, INC | · | -$76,398 | · | · | · | 4 |
| NIKINiki BioSolutions, Inc. | · | -$1.4 M | · | -6.2% | · | 3 |
| NMADNOMAD POWER SOLUTIONS, INC. | · | -$6.1 M | · | -115.9% | · | 5 |
| NUMDNu-Med Plus, Inc. | · | -$56,182 | · | · | · | 9 |
| ODYYOdyssey Health, Inc. | · | -$1.7 M | · | · | · | 6 |
| OGENORAGENICS INC | · | -$9.8 M | · | · | · | 12 |
| OMEROMEROS CORP | · | -$3.4 M | · | · | · | 12 |
| ORKAOruka Therapeutics, Inc. | · | -$105.4 M | · | -22.3% | · | 10 |
| OTLCOncotelic Therapeutics, Inc. | · | $249.3 M | · | 184.0% | · | 4 |
| PHIOPhio Pharmaceuticals Corp. | · | -$8.7 M | · | -69.9% | · | 8 |
| PKTXProtoKinetix, Inc. | · | -$393,650 | · | -123.0% | · | 5 |
| PPBTPURPLE BIOTECH LTD. | · | -$26.4 M | · | -124.0% | · | 4 |
| PULMPulmatrix, Inc. | · | -$5.2 M | · | -80.9% | · | 12 |
| PVLAPALVELLA THERAPEUTICS, INC. | · | -$41.7 M | · | -92.1% | · | 11 |
| QCLSQ/C TECHNOLOGIES, INC. | · | -$11.6 M | · | -73.7% | · | 7 |
| QNRXQuoin Pharmaceuticals Ltd. | · | -$15.8 M | · | -141.6% | · | 3 |
| QNTMQuantum Biopharma Ltd. | · | · | · | · | · | 1 |
| RDGLVIVOS INC | · | -$3.1 M | · | -161.0% | · | 12 |
| SIGYSigyn Therapeutics, Inc. | · | -$3.3 M | · | · | · | 5 |
| SLDBSolid Biosciences Inc. | · | -$174.3 M | · | -109.9% | · | 7 |
| SLSSELLAS Life Sciences Group, Inc. | · | -$26.9 M | · | -66.9% | · | 7 |
| SNGXSOLIGENIX, INC. | · | -$11.1 M | · | -235.5% | · | 15 |
| STMEStimcell Energetics Inc. | · | -$895,375 | · | · | · | 8 |
| SVRASavara Inc | · | -$118.8 M | · | -63.5% | · | 9 |
| TLSATiziana Life Sciences Ltd | · | -$11.9 M | · | -250.5% | · | 0 |
| TPSTTempest Therapeutics, Inc. | · | -$26.3 M | · | -203.6% | · | 5 |
| TRFATRAFALGAR INTERNATIONAL, INC. | · | -$331,612 | · | · | · | 5 |
| TVRDTvardi Therapeutics, Inc. | · | -$18.2 M | · | · | · | 13 |
| VERUVERU INC. | · | -$22.7 M | · | -89.7% | · | 16 |
| VISKViskase Holdings, Inc. | · | -$3.4 M | · | · | · | 15 |
| WINTWINDTREE THERAPEUTICS INC | · | -$1.8 M | · | -26.7% | · | 8 |
| XBITXBiotech Inc. | · | -$45.5 M | · | -28.2% | · | 6 |
| XRTXXORTX Therapeutics Inc. | · | -CAD 1.7 M | · | -18.4% | · | 0 |
| CAICaris Life Sciences, Inc. | $812.0 M | -$68.1 M | -8.4% | · | · | 3 |
| CRLBFCresco Labs Inc. | $655.8 M | -$135.4 M | -21.4% | -33.2% | · | 3 |
| CDRECadre Holdings, Inc. | $610.3 M | $44.1 M | 7.2% | 14.0% | +8.6% | 6 |
| AAWHAscend Wellness Holdings, Inc. | $500.6 M | -$118.2 M | -23.6% | · | +28.3% | 7 |
| AYRWFAyr Wellness Inc. | $463.6 M | -$359.3 M | -78.2% | -74.8% | · | 3 |
| VREOFVireo Growth Inc. | $268.8 M | -$68.1 M | -25.3% | -37.5% | +40.4% | 6 |
| JUSHJushi Holdings Inc. | $262.9 M | -$68.6 M | -26.1% | · | +26.6% | 6 |
| LUNRIntuitive Machines, Inc. | $210.1 M | -$83.3 M | -50.9% | · | · | 4 |
| GLASGlass House Brands Inc. | $182.0 M | -$29.7 M | -15.9% | -31.2% | +30.4% | 6 |
| MRMDMARIMED INC. | $159.8 M | -$14.5 M | -9.0% | -26.7% | +25.7% | 15 |
| AIRSAirsculpt Technologies, Inc. | $151.8 M | -$11.7 M | -7.7% | -14.1% | +19.3% | 7 |
| GLUEMonte Rosa Therapeutics, Inc. | $123.7 M | -$38.6 M | -31.2% | -16.9% | · | 3 |
| IPSCCentury Therapeutics, Inc. | $109.2 M | -$9.6 M | -8.8% | -6.0% | · | 4 |
| BBNXBeta Bionics, Inc. | $100.3 M | -$73.2 M | -73.0% | · | · | 3 |
| SGHTSight Sciences, Inc. | $77.4 M | -$38.4 M | -49.7% | -50.7% | +22.9% | 6 |
| CVRXCVRx, Inc. | $56.7 M | -$53.3 M | -94.1% | -96.6% | +56.4% | 6 |
| IVVDInvivyd, Inc. | $53.4 M | -$52.5 M | -98.2% | -34.0% | · | 3 |
| SEPNSepterna, Inc. | $46.0 M | -$48.9 M | -106.4% | -12.2% | · | 3 |
| BFRIBiofrontera Inc. | $41.7 M | -$10.5 M | -25.3% | -141.3% | +17.2% | 6 |
| TKNOAlpha Teknova, Inc. | $40.5 M | -$17.3 M | -42.6% | -22.8% | +5.3% | 6 |
| BHSTBIOHARVEST SCIENCES INC. | $34.5 M | -$11.1 M | -32.3% | -83.2% | · | 3 |
| SCLXScilex Holding Co | $30.3 M | -$374.1 M | -1236.4% | · | +5.1% | 6 |
| OPTXSYNTEC OPTICS HOLDINGS, INC. | $28.1 M | -$1.8 M | -6.4% | -17.4% | · | 4 |
| TRDAEntrada Therapeutics, Inc. | $25.4 M | -$143.8 M | -565.5% | -39.1% | · | 3 |
| MGXMetagenomi Therapeutics, Inc. | $25.2 M | -$87.9 M | -348.5% | -44.7% | · | 3 |
| MDAISpectral AI, Inc. | $19.6 M | -$7.6 M | -38.5% | · | · | 4 |
| QTIQT IMAGING HOLDINGS, INC. | $18.9 M | -$21.1 M | -111.4% | · | · | 4 |
| MITQMOVING iMAGE TECHNOLOGIES INC. | $17.3 M | -$297,000 | -1.7% | -6.3% | +19.0% | 6 |
| ALURALLURION TECHNOLOGIES, INC. | $15.2 M | -$28.8 M | -188.8% | · | · | 4 |
| HYPRHyperfine, Inc. | $13.6 M | -$35.6 M | -262.3% | -79.0% | +115.2% | 6 |
| ELUTELUTIA INC. | $12.3 M | $53.4 M | 434.2% | · | -22.0% | 7 |
| NXGLNEXGEL, INC. | $11.4 M | -$3.0 M | -25.3% | -58.7% | +76.1% | 8 |
| CRBUCaribou Biosciences, Inc. | $11.2 M | -$148.1 M | -1327.4% | -79.0% | -2.0% | 7 |
| TCRXTScan Therapeutics, Inc. | $10.3 M | -$129.8 M | -1256.8% | -71.3% | +56.9% | 6 |
| ZBIOZenas BioPharma, Inc. | $10.0 M | -$377.7 M | · | -136.2% | · | 3 |
| COYACoya Therapeutics, Inc. | $7.9 M | -$21.2 M | -267.1% | -51.4% | · | 4 |
| BOLTBolt Biotherapeutics, Inc. | $7.7 M | -$33.4 M | -433.7% | -79.7% | +101.6% | 6 |
| BGLCBioNexus Gene Lab Corp | $7.4 M | -$3.0 M | -40.2% | -35.2% | -8.2% | 8 |
| NIVFNewGenIvf Group Ltd | $4.7 M | $9.9 M | 205.8% | · | · | 5 |
| LUCDLucid Diagnostics Inc. | $4.7 M | -$58.0 M | -1232.7% | -710.6% | · | 5 |
| TNONTenon Medical, Inc. | $3.9 M | -$12.6 M | -318.4% | -228.1% | · | 5 |
| NRXSNeuraxis, INC | $3.6 M | -$7.8 M | -218.5% | -285.4% | · | 4 |
| CAMPCamp4 Therapeutics Corp | $3.5 M | -$80.4 M | · | -145.1% | · | 3 |
| UPBUpstream Bio, Inc. | $2.9 M | -$143.4 M | · | -35.4% | · | 3 |
| LUCYInnovative Eyewear Inc | $2.7 M | -$7.6 M | -285.2% | -83.6% | · | 5 |
| PLSHPANACEA LIFE SCIENCES HOLDINGS, INC. | $2.4 M | -$8.0 M | -336.1% | · | · | 10 |
| RNLXYRenalytix plc | $2.3 M | -$33.5 M | · | · | · | 5 |
| NTRBNutriBand Inc. | $2.0 M | -$8.2 M | -404.1% | -125.6% | +16.6% | 8 |
| INBXInhibrx Biosciences, Inc. | $1.3 M | -$140.1 M | · | -197.8% | · | 3 |
| ICUSeaStar Medical Holding Corp | $1.2 M | -$12.2 M | -984.6% | · | · | 3 |
| LGVNLongeveron Inc. | $1.2 M | -$22.7 M | · | -164.7% | -26.6% | 6 |
| PETVPetVivo Holdings, Inc. | $1.1 M | -$10.5 M | -917.4% | -326.3% | +146.4% | 12 |
| BSPKBespoke Extracts, Inc. | $1.1 M | -$1.0 M | · | · | · | 6 |
| SXTP60 DEGREES PHARMACEUTICALS, INC. | $1.0 M | -$7.4 M | -732.8% | -196.4% | · | 4 |
| PROKPROKIDNEY CORP. | $893,000 | -$69.0 M | · | · | · | 4 |
| ESYNHWH International Inc. | $866,926 | -$2.6 M | -306.6% | -97.7% | · | 3 |
| ONCOOnconetix, Inc. | $815,371 | -$14.0 M | · | -115.5% | · | 3 |
| ELABPMGC Holdings Inc. | $590,084 | -$7.7 M | -1313.0% | -106.9% | · | 3 |
| LIPOLIPELLA PHARMACEUTICALS INC. | $536,357 | -$5.0 M | -935.2% | -198.1% | · | 4 |
| MGRXMANGOCEUTICALS, INC. | $456,021 | -$20.6 M | · | -141.6% | · | 4 |
| HINDVyome Holdings, Inc | $319,714 | -$10.3 M | · | · | -51.0% | 12 |
| GLUCGlucose Health, Inc. | $313,229 | -$410,443 | · | · | · | 5 |
| NXLNexalin Technology, Inc. | $301,647 | -$8.2 M | · | -221.5% | · | 5 |
| COCHEnvoy Medical, Inc. | $241,000 | -$23.8 M | · | · | · | 4 |
| BFRGBullFrog AI Holdings, Inc. | $116,670 | -$6.5 M | · | -183.0% | · | 3 |
| SERASERA PROGNOSTICS, INC. | $81,000 | -$31.9 M | · | -51.8% | +26.5% | 6 |
| CNTBConnect Biopharma Holdings Ltd | $64,000 | -$55.5 M | · | -82.7% | · | 3 |
| HCWBHCW Biologics Inc. | $54,232 | -$8.0 M | · | · | · | 6 |
| SNTISenti Biosciences Holdings, Inc. | $22,000 | -$61.4 M | · | -393.4% | · | 5 |
| CDIOCardio Diagnostics Holdings, Inc. | $14,825 | -$6.5 M | · | -78.6% | · | 5 |
| KAYSKaya Holdings, Inc. | $7,134 | -$2.1 M | · | · | -62.9% | 11 |
| AMIXAutonomix Medical, Inc. | $0 | -$16.7 M | · | -238.9% | · | 4 |
| ARTVArtiva Biotherapeutics, Inc. | $0 | -$83.9 M | · | -56.5% | · | 3 |
| AZTRAzitra, Inc. | $0 | -$11.0 M | · | -230.7% | · | 4 |
| BRNSBarinthus Biotherapeutics plc. | $0 | -$66.4 M | · | -65.0% | · | 6 |
| CNBXCNBX Pharmaceuticals Inc. | $0 | -$313,976 | · | · | · | 11 |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | $0 | -$38.6 M | · | -66.8% | · | 3 |
| GIPLGlobal Innovative Platforms Inc. | $0 | -$718,251 | · | · | · | 5 |
| GUTSFRACTYL HEALTH, INC. | $0 | -$141.0 M | · | -744.2% | · | 3 |
| SABSSAB Biotherapeutics, Inc. | $0 | $13.3 M | · | 15.0% | · | 6 |
| ACBAURORA CANNABIS INC | CAD 343.3 M | CAD 1.6 M | 0.5% | 0.3% | · | 7 |
| OGIORGANIGRAM GLOBAL INC. | CAD 159.8 M | -CAD 45.4 M | -28.4% | -14.9% | · | 6 |
| PYRGFPyroGenesis Canada Inc. | CAD 19.0 M | -CAD 32.2 M | -169.2% | -111.6% | · | 4 |
| BMGLBasel Medical Group Ltd | SGD 11.3 M | -SGD 10.6 M | -94.0% | -163.6% | · | 2 |
| CUPRCuprina Holdings (Cayman) LTD | SGD 49,894 | -SGD 4.7 M | · | · | · | 4 |
| BFNHBIOFORCE NANOSCIENCES HOLDINGS, INC. | · | -$1.3 M | · | · | · | 3 |
| CADLCandel Therapeutics, Inc. | · | -$38.2 M | · | -64.6% | · | 3 |
| CTORCITIUS ONCOLOGY, INC. | · | -$24.8 M | · | -54.4% | · | 0 |
| ELTXElicio Therapeutics, Inc. | · | -$39.6 M | · | · | · | 3 |
| FCHSFirst Choice Healthcare Solutions, Inc. | · | -$7.0 M | · | · | · | 4 |
| GANXGain Therapeutics, Inc. | · | -$20.2 M | · | -155.7% | · | 4 |
| KTTAPasithea Therapeutics Corp. | · | -$20.4 M | · | -58.4% | · | 2 |
| MAIAMAIA Biotechnology, Inc. | · | -$22.4 M | · | -745.2% | · | 3 |
| NXTSNexentis Technologies Inc. | · | -$4.0 M | · | -38.6% | · | 7 |
| PCSAProcessa Pharmaceuticals, Inc. | · | -$13.6 M | · | -373.0% | · | 7 |
| PTPIPetros Pharmaceuticals, Inc. | · | $1.9 M | · | · | · | 5 |
| VBIOValion Bio, Inc. | · | -$8.9 M | · | -91.8% | · | 4 |
Ordered by filer size, then revenue. Size comes from the SEC filer category, which uses public float — the measure of scale available without a price feed. "·" marks a figure not available in our data.